header logo image


Page 11«..10111213..20..»

Archive for the ‘Stem Cell Russia’ Category

Human Embryonic Stem Cell Assay Market Overview, Top Companies, Region, Application and Global Forecast by 2026 – Latest Herald

Tuesday, April 28th, 2020

The world is not only fighting a health pandemic but also an economic one, as the Novel Coronavirus (COVID 19) casts its long shadow over economies around the globe. The complete lockdown situation in several countries, has directly or indirectly impacted many industries causing a shift in activities like supply chain operations, vendor operations, product commercialization, etc. In the latest report on Human Embryonic Stem Cell Assay Market, published by Market Research Intellect, numerous aspects of the current market scenario have been taken into consideration and a concise analysis has been put together to bring you with a study that has Pre- and Post-COVID market analysis. Our analysts are watching closely, the growth and decline in each sector due to COVID 19, to offer you with quality services that you need for your businesses. The report encompasses comprehensive information pertaining to the driving factors, detailed competitive analysis about the key market entities and relevant insights regarding the lucrative opportunities that lie in front of the industry players to mitigate risks in such circumstances.

It offers detailed research and analysis of key aspects of the global Human Embryonic Stem Cell Assay market. The market analysts authoring this report has provided detailed information on growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Human Embryonic Stem Cell Assay market. Market participants can use the market analysis to plan effective growth strategies and prepare for future challenges in advance. Each trend in the global Human Embryonic Stem Cell Assay market is carefully analyzed and investigated by market analysts.

For Better Understanding, Download Sample PDF Copy of Human Embryonic Stem Cell Assay Market Research Report @ https://www.marketresearchintellect.com/download-sample/?rid=203853&utm_source=LHN&utm_medium=888

**Our SAMPLE COPY of the report gives a brief introduction of the Human Embryonic Stem Cell Assay market, Detailed TOC, key players of the market, list of tables and figures and comprising key countries regions.**

The Major Players in Global Human Embryonic Stem Cell Assay Market:

Global Human Embryonic Stem Cell Assay Market Segmentation

This market was divided into types, applications and regions. The growth of each segment provides an accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026. This analysis can help you develop your business by targeting niche markets. Market share data are available at global and regional levels. The regions covered by the report are North America, Europe, the Asia-Pacific region, the Middle East, and Africa and Latin America. Research analysts understand the competitive forces and provide competitive analysis for each competitor separately.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=203853&utm_source=LHN&utm_medium=888

Human Embryonic Stem Cell Assay Market Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Some Notable Report Offerings:

-> We will give you an assessment of the extent to which the market acquire commercial characteristics along with examples or instances of information that helps your assessment.

-> We will also support to identify standard/customary terms and conditions such as discounts, warranties, inspection, buyer financing, and acceptance for the Human Embryonic Stem Cell Assay industry.

-> We will further help you in finding any price ranges, pricing issues, and determination of price fluctuation of products in Human Embryonic Stem Cell Assay industry.

-> Furthermore, we will help you to identify any crucial trends to predict Human Embryonic Stem Cell Assay market growth rate up to 2026.

-> Lastly, the analyzed report will predict the general tendency for supply and demand in the Human Embryonic Stem Cell Assay market.

Have Any Query? Ask Our Expert@ https://www.marketresearchintellect.com/need-customization/?rid=203853&utm_source=LHN&utm_medium=888

Table of Contents:

Study Coverage: It includes study objectives, years considered for the research study, growth rate and Human Embryonic Stem Cell Assay market size of type and application segments, key manufacturers covered, product scope, and highlights of segmental analysis.

Executive Summary: In this section, the report focuses on analysis of macroscopic indicators, market issues, drivers, and trends, competitive landscape, CAGR of the global Human Embryonic Stem Cell Assay market, and global production. Under the global production chapter, the authors of the report have included market pricing and trends, global capacity, global production, and global revenue forecasts.

Human Embryonic Stem Cell Assay Market Size by Manufacturer: Here, the report concentrates on revenue and production shares of manufacturers for all the years of the forecast period. It also focuses on price by manufacturer and expansion plans and mergers and acquisitions of companies.

Production by Region: It shows how the revenue and production in the global market are distributed among different regions. Each regional market is extensively studied here on the basis of import and export, key players, revenue, and production.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Human Embryonic Stem Cell Assay Market Size, Human Embryonic Stem Cell Assay Market Growth, Human Embryonic Stem Cell Assay Market Forecast, Human Embryonic Stem Cell Assay Market Analysis

Our Trending Reports

Veterinary Fecal Filters Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Veterinary Grooming Aids Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Veterinary Test Strips Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

More here:
Human Embryonic Stem Cell Assay Market Overview, Top Companies, Region, Application and Global Forecast by 2026 - Latest Herald

Read More...

Cell Culture Media Market 2020 Future Growth Prospects and Trends | STEMCELL Technologies China Co. Ltd., ScienCell, Procell and Others – Cole of…

Tuesday, April 28th, 2020

Futuristic Reports, The growth and development of Global Cell Culture Media Market Report 2020 by Players, Regions, Type, and Application, forecast to 2026 provides industry analysis and forecast from 2020-2026. Global Cell Culture Media Market analysis delivers important insights and provides a competitive and useful advantage to the pursuers. Cell Culture Media processes, economic growth is analyzed as well. The data chart is also backed up by using statistical tools.

Simultaneously, we classify different Cell Culture Media markets based on their definitions. Downstream consumers and upstream materials scrutiny are also carried out. Each segment includes an in-depth explanation of the factors that are useful to drive and restrain it.

Key Players Mentioned in the study are STEMCELL Technologies China Co. Ltd., ScienCell, Procell, Jianshun, Morecell, Sartorius, CDH, Imv India Pvt Ltd, Cellapy, Basal Media, Opmbiosciences, Suzhou world-medium Biotechnology Co. Ltd, Akshar Enterprises, Beijing Zoman Biotechnology Co. Ltd, Tm Media

For Better Understanding, Download FREE Sample Copy of Cell Culture Media Market Report @ https://www.futuristicreports.com/request-sample/53428

Key Issues Addressed by Cell Culture Media Market: It is very significant to have Cell Culture Media segmentation analysis to figure out the essential factors of growth and development of the market in a particular sector. The Cell Culture Media report offers well summarized and reliable information about every segment of growth, development, production, demand, types, application of the specific product which will be useful for players to focus and highlight on.

Businesses Segmentation of Cell Culture Media Market:

On the basis on the applications, this report focuses on the status and Cell Culture Media outlook for major applications/end users, sales volume, and growth rate for each application, including-

Biopharmaceutical Manufacturing Tissue-culture & Manufacturing Gene Therapy Cytogenetic Others

On the basis of types/products, this Cell Culture Media report displays the revenue (Million USD), product price, market share, and growth rate of each type, split into-

Classical Media & Salts Serum-free Media Stem Cell Media Others

Grab Best Discount on Cell Culture Media Market Research Report [Single User | Multi User | Corporate Users] @ https://www.futuristicreports.com/check-discount/53428

NOTE: Our team is studying Covid-19 impact analysis on various industry verticals and Country Level impact for a better analysis of markets and industries. The 2020 latest edition of this report is entitled to provide additional commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation.

OR

You just drop an Email to: [emailprotected] us if you are looking for any Economical shift towards the New Normal on any Country or Industry Verticals.

Cell Culture Media Market Regional Analysis Includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (the United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.)

Cell Culture Media Insights that Study is going to provide:

Gain perceptive study of this current Cell Culture Media sector and also possess a comprehension of the industry; Describe the Cell Culture Media advancements, key issues, and methods to moderate the advancement threats; Competitors In this chapter, leading players are studied with respect to their company profile, product portfolio, capacity, price, cost, and revenue. A separate chapter on Cell Culture Media market structure to gain insights on Leaders confrontational towards market [Merger and Acquisition / Recent Investment and Key Developments] Patent Analysis** Number of patents filed in recent years.

Table of Content:

Global Cell Culture Media Market Size, Status and Forecast 20261. Market Introduction and Market Overview2. Industry Chain Analysis3. Cell Culture Media Market, by Type4. Cell Culture Media Market, by Application5. Production, Value ($) by Regions6. Production, Consumption, Export, Import by Regions (2016-2020)7. Market Status and SWOT Analysis by Regions (Sales Point)8. Competitive Landscape9. Analysis and Forecast by Type and Application10. Channel Analysis11. New Project Feasibility Analysis12. Market Forecast 2020-202613. Conclusion

Enquire More Before Buying @ https://www.futuristicreports.com/send-an-enquiry/53428

For More Information Kindly Contact:

Futuristic ReportsTel: +1-408-520-9037Media Release: https://www.futuristicreports.com/press-releases

Follow us on Blogger @ https://futuristicreports.blogspot.com/

See the article here:
Cell Culture Media Market 2020 Future Growth Prospects and Trends | STEMCELL Technologies China Co. Ltd., ScienCell, Procell and Others - Cole of...

Read More...

Addressing the potential impact of coronavirus disease (COVID-19) on Cell Harvesting System Market Forecast to 2025 Driven by Industry Major Players,…

Tuesday, April 28th, 2020

The report on the Cell Harvesting System market provides a birds eye view of the current proceeding within the Cell Harvesting System market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Cell Harvesting System market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Cell Harvesting System market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

The recent published research report sheds light on critical aspects of the global Cell Harvesting System market such as vendor landscape, competitive strategies, market drivers and challenges along with the regional analysis. The report helps the readers to draw a suitable conclusion and clearly understand the current and future scenario and trends of global Cell Harvesting System market. The research study comes out as a compilation of useful guidelines for players to understand and define their strategies more efficiently in order to keep themselves ahead of their competitors. The report profiles leading companies of the global Cell Harvesting System market along with the emerging new ventures who are creating an impact on the global market with their latest innovations and technologies.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2638970&source=atm

The recent published study includes information on key segmentation of the global Cell Harvesting System market on the basis of type/product, application and geography (country/region). Each of the segments included in the report is studies in relations to different factors such as market size, market share, value, growth rate and other quantitate information.

The competitive analysis included in the global Cell Harvesting System market study allows their readers to understand the difference between players and how they are operating amounts themselves on global scale. The research study gives a deep insight on the current and future trends of the market along with the opportunities for the new players who are in process of entering global Cell Harvesting System market. Market dynamic analysis such as market drivers, market restraints are explained thoroughly in the most detailed and easiest possible manner. The companies can also find several recommendations improve their business on the global scale.

The readers of the Cell Harvesting System Market report can also extract several key insights such as market size of varies products and application along with their market share and growth rate. The report also includes information for next five years as forested data and past five years as historical data and the market share of the several key information.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2638970&source=atm

Global Cell Harvesting System Market by Companies:

The company profile section of the report offers great insights such as market revenue and market share of global Cell Harvesting System market. Key companies listed in the report are:

The key players covered in this studyPerkinelmerTomtecCOX ScientificConnectorateScinomixSartoriusADS BiotecGeneral ElectricTerumo Bct

Market segment by Type, the product can be split intoManual Cell HarvestersAutomated Cell HarvestersMarket segment by Application, split intoStem Cell ResearchOther Applications

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaJapanSoutheast AsiaIndiaCentral & South America

The study objectives of this report are:To analyze global Cell Harvesting System status, future forecast, growth opportunity, key market and key players.To present the Cell Harvesting System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cell Harvesting System are as follows:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year 2020 to 2026For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Cell Harvesting System Market by Geography:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2638970&licType=S&source=atm

Some of the Major Highlights of TOC covers in Cell Harvesting System Market Report:

Chapter 1: Methodology & Scope of Cell Harvesting System Market

Chapter 2: Executive Summary of Cell Harvesting System Market

Chapter 3: Cell Harvesting System Industry Insights

Chapter 4: Cell Harvesting System Market, By Region

Chapter 5: Company Profile

And Continue

Here is the original post:
Addressing the potential impact of coronavirus disease (COVID-19) on Cell Harvesting System Market Forecast to 2025 Driven by Industry Major Players,...

Read More...

Insect Cell Culture Market Is Set To Experience Revolutionary Growth By 2025 – Latest Herald

Tuesday, April 28th, 2020

Research report on global Insect Cell Culture Market 2020 with industry-primary research, secondary research, product research, size, trends, and Forecast.

The Insect Cell Culture report provides independent information about the Insect Cell Culture industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porters five force analysis, and key companies profiles including business overview and recent development.

Download Premium Sample Copy Of This Report: Download FREE Sample PDF!

In this report, our team offers a thorough investigation of Insect Cell Culture Market, SWOT examination of the most prominent players right now. Alongside an industrial chain, market measurements regarding revenue, sales, value, capacity, regional market examination, section insightful information, and market forecast are offered in the full investigation, and so forth.

Scope of Insect Cell Culture Market: Products in the Insect Cell Culture classification furnish clients with assets to get ready for tests, tests, and evaluations.

Major Company Profiles Covered in This Report

Life Technologies, Corning (Cellgro), Sigma-Aldrich, Thermo Fisher, Merck Millipore, GE Healthcare, Lonza, BD, HiMedia, Takara, CellGenix, Atlanta Biologicals, PromoCell

Table Of Content

Market Overview: Scope & Product Overview, Classification of Insect Cell Culture by Product Category (Market Size (Sales), Market Share Comparison by Type (Product Category)), Insect Cell Culture Market by Application/End Users (Sales (Volume) and Market Share Comparison by Application), Market by Region (Market Size (Value) Comparison by Region, Status and Prospect

Insect Cell Culture Market by Manufacturing Cost Analysis: Key Raw Materials Analysis, Price Trend of Key Raw Materials, Key Suppliers of Raw Materials, Market Concentration Rate of Raw Materials, Proportion of Manufacturing Cost Structure (Raw Materials, Labor Cost), Manufacturing Process Analysis

Insect Cell Culture Market Report Covers the Following Segments:

Segment by Type:

Classical Media & SaltsSerum-free MediaStem Cell Media

Segment by Application:

Biopharmaceutical ManufacturingTissue Culture & EngineeringGene TherapyCytogenetic

North America

Europe

Asia-Pacific

South America

Center East and Africa

United States, Canada and Mexico

Germany, France, UK, Russia and Italy

China, Japan, Korea, India and Southeast Asia

Brazil, Argentina, Colombia

Saudi Arabia, UAE, Egypt, Nigeria and South Africa

Key Benefits for Stakeholders

The study provides an in-depth analysis of the Insect Cell Culture market size along with the current trends and future estimations to elucidate the imminent investment pockets.

Information about key drivers, restraints, and opportunities and their impact analysis on the market size is provided.

Porters five forces analysis illustrates the potency of buyers and suppliers operating in the portable gaming industry.

The quantitative analysis of the Insect Cell Culture industry from 2020 to 2026 is provided to determine the Insect Cell Culture market potential.

About (Market Research Bazaar):

Market Research Bazaar (MRB)- a part of VRRB Reports LLP is an overall Market Research and consulting organization. We give unparalleled nature of offering to our clients present all around the world crosswise over industry verticals. Market Research Bazaar has aptitude in giving profound jump showcase understanding alongside advertise knowledge to our clients spread across over different endeavours.

Media Contact:

Market Research Bazaar

UK: +442070973908

US: +13156360953

India: +919548234540

Email:[emailprotected]

Website:http://marketresearchbazaar.com/

Blog:http://marketresearchbazaar.com/blogs

Excerpt from:
Insect Cell Culture Market Is Set To Experience Revolutionary Growth By 2025 - Latest Herald

Read More...

Global Animal Stem Cell Therapy Market 2020 Future Scenario, Industry Growth Insights and Production Analysis 2025 – Bandera County Courier

Saturday, April 25th, 2020

Mrinsights.bizhas published a new report titled GlobalAnimal Stem Cell TherapyMarketGrowth 2020-2025 which comprises new statistical data on the changing market scenario and initial and future assessment of the market. The report covers a wide range of business aspects global Animal Stem Cell Therapy trends, future forecasts, growth opportunities, key end-user industries, and market players. The report analyzes the recent developments, investment opportunities, and probable threats in the market. It closely looks at the markets all-purpose evaluation and depicts the important data associated with the global market.

DOWNLOAD FREE SAMPLE REPORT:https://www.mrinsights.biz/report-detail/232664/request-sample

The report assesses the demand-side and supply-side trends in the global Animal Stem Cell Therapy market. Various segments are scrutinized that involve end-users, regions, and players on the basis of demand patterns, and prospect for 2020 to 2025 time-period. The research report contains a comprehensive database on future market estimation based on historical data analysis. Key players are listed with major collaborations, mergers & acquisitions and upcoming and trending innovation. Primary research involves interviews, news sources and information booths. Secondary research techniques add more in clear and concise understanding with regards to placing of data in the report.

Understanding The Competitive Scenario:

Competitive landscape analysis is presented which involves the global Animal Stem Cell Therapy market share of major players, along with the new projects and strategies adopted by players in the past five years. Comprehensive company profiles comprise the product offerings, key financial information, recent developments, SWOT analysis, capacity, production, price, revenue, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, and strategies employed by the major market players. Additionally, the report covers insights into the production and capacities in terms of manufacturing with price fluctuations of raw materials, process in-flow rate product cost, and production value.

Considering market analysis, the profiled list of companies in the report is:Medivet Biologics LLC, Animal Cell Therapies, VETSTEM BIOPHARMA, U.S. Stem Cell, Inc, VetCell Therapeutics, J-ARM, Kintaro Cells Power, Celavet Inc., Animal Stem Care, Magellan Stem Cells, Cell Therapy Sciences, Animacel

Currently, the research report gives special attention and focus on the following regions:Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia, Spain), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries).

Moreover, the report identifies potential customers and suppliers as well as gives an analysis of the companys business structure, operations, major products and services, and business strategy. The study helps you understand the companys core strengths, weaknesses, opportunities, and threats. The report shows factual data about the global Animal Stem Cell Therapy market in the worldwide area, for example, production chain, manufacturing capacity, sales volume, and revenue.

ACCESS FULL REPORT:https://www.mrinsights.biz/report/global-animal-stem-cell-therapy-market-growth-2020-2025-232664.html

The Scope of The Global Animal Stem Cell Therapy Report:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@mrinsights.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

The rest is here:
Global Animal Stem Cell Therapy Market 2020 Future Scenario, Industry Growth Insights and Production Analysis 2025 - Bandera County Courier

Read More...

Animal Stem Cell Therapy Market Is Set To Experience Revolutionary Growth By 2025 – Cole of Duty

Saturday, April 25th, 2020

The Animal Stem Cell Therapy report provides independent information about the Animal Stem Cell Therapy industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porters five force analysis, and key companies profiles including business overview and recent development.

Animal Stem Cell Therapy MarketLatest Research Report 2020:

Download Premium Sample Copy Of This Report: Download FREE Sample PDF!

In this report, our team offers a thorough investigation of Animal Stem Cell Therapy Market, SWOT examination of the most prominent players right now. Alongside an industrial chain, market measurements regarding revenue, sales, value, capacity, regional market examination, section insightful information, and market forecast are offered in the full investigation, and so forth.

Scope of Animal Stem Cell Therapy Market: Products in the Animal Stem Cell Therapy classification furnish clients with assets to get ready for tests, tests, and evaluations.

Animal Stem Cell Therapy Market Report Covers the Following Segments:

Segment1: By Type, Dogs, Horses, Others, By Application, Veterinary Hospitals, Research Organizations

Market Overview:The report begins with this section where product overview and highlights of product and application segments of the global Animal Stem Cell Therapy Market are provided. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

Competition by Company:Here, the competition in the Worldwide Animal Stem Cell Therapy Market is analyzed, By price, revenue, sales, and market share by company, market rate, competitive situations Landscape, and latest trends, merger, expansion, acquisition, and market shares of top companies.

Company Profiles and Sales Data:As the name suggests, this section gives the sales data of key players of the global Animal Stem Cell Therapy Market as well as some useful information on their business. It talks about the gross margin, price, revenue, products, and their specifications, type, applications, competitors, manufacturing base, and the main business of key players operating in the global Animal Stem Cell Therapy Market.

Market Status and Outlook by Region:In this section, the report discusses about gross margin, sales, revenue, production, market share, CAGR, and market size by region. Here, the global Animal Stem Cell Therapy Market is deeply analyzed on the basis of regions and countries such as North America, Europe, China, India, Japan, and the MEA.

Application or End User:This section of the research study shows how different end-user/application segments contribute to the global Animal Stem Cell Therapy Market.

Market Forecast:Here, the report offers a complete forecast of the global Animal Stem Cell Therapy Market by product, application, and region. It also offers global sales and revenue forecast for all years of the forecast period.

Research Findings and Conclusion:This is one of the last sections of the report where the findings of the analysts and the conclusion of the research study are provided.

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Top Trending Reports:

https://www.marketwatch.com/press-release/at-1905-cagr-pop-up-cinema-market-size-to-surpass-us-197229-million-by-2025-2020-04-24

https://www.marketwatch.com/press-release/at-1905-cagr-pop-up-cinema-market-size-to-surpass-us-197229-million-by-2025-2020-04-24

https://www.marketwatch.com/press-release/ipaas-integration-platform-as-a-service-market-size-share-application-analysis-regional-outlook-growth-trends-top-key-players-and-competitive-strategiesforecast-to-2025-2020-04-24?tesla=y

https://www.marketwatch.com/press-release/microwave-transmission-equipment-market-2020-share-trends-segmentation-and-forecast-by-2025-cagr-of-314-2020-04-24-61763810?tesla=y

http://marketwatch.com/press-release/military-drone-market-share-size-future-demand-global-research-top-leading-player-emerging-trends-region-by-forecast-to-2025-2020-04-24?tesla=y

Read the original here:
Animal Stem Cell Therapy Market Is Set To Experience Revolutionary Growth By 2025 - Cole of Duty

Read More...

Global Cell Sorting Market 2020 Industry Analysis by Manufacturers, Type, Application, End-User and Forecast 2025 – Bandera County Courier

Saturday, April 25th, 2020

A new research study titled Global Cell Sorting Market Report 2020, Forecast to 2025 has been presented by Magnifier Research which offers a comprehensive analysis on the market. Users can benefit from this complete market research report with all the required useful information about this market. The report covers the important components related to the top sellers of the global Cell Sorting industry that influence the market. However, it inspects the primary formats changing the dynamics of the market. Likewise, it covers related current affairs, which will be influencing the market. What more, it simplifies the essential sections and also the sub-sections that represents the recent zone.

Key Components Covered in The Report:

The research document is a detailed study on the growth, investment opportunities, market statistics, growing competition analysis, major key players, industry facts, important figures, sales, prices, revenues, gross margins, market shares, business strategies, top regions, demand, and developments. The report further estimates the global Cell Sorting industry esteem chain, powerful business strategies, cost, structure, creation limit, conveyance, market range, and limits usage rate. The market provides basic information of market members and organizing profiling, contact data, item/benefit beds, income development, revenue generation, and gross deals. This study also provides sales, revenue, and market share for each player covered in this report for a period between 2015 and 2020.

DOWNLOAD FREE SAMPLE REPORT: https://www.magnifierresearch.com/report-detail/37752/request-sample

Following are the topmost key players covered in this global Cell Sorting market research report:- NanoCellect Biomedical, Innovative Biochips, Cesca Therapeutics, Fluidigm, LumaCyte, Union Biometrica, LevitasBio, RareCyte, Cytonome, Namocell, STEMCELL Technologies, Akadeum Life Sciences

Together with geography at the worldwide forecast to 2025 is just absolutely professional and thorough. Moreover, the research study lists the major regional countries, focusing on the remarkable regions:- North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

The market segment based on product type includes:- Cancer Cell, Immune Cells, Microbial Cell, Red Blood Cell/Platelet, Stem Cell, Other

Applications mentioned in this report:- Cell Research, Biomedical Diagnosis, Other

Furthermore, the global Cell Sorting market has been divided into types, applications, and regions. This data provides a detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market. The report further includes market shares for 2015 and 2025, for each of the above-mentioned segments. It also highlights the export and import of the market. It also analyses the regional distribution of the industry in terms of development trends.

ACCESS FULL REPORT: https://www.magnifierresearch.com/report/global-cell-sorting-market-report-2020-forecast-to-37752.html

Points Covered In This Report:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@magnifierresearch.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Magnifier Research is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Magnifier Research also specializes in analyzing hi-tech systems and current processing systems in its expertise. We have a team of experts that compile precise research reports and actively advise top companies to improve their existing processes. Our experts have extensive experience in the topics that they cover. Magnifier Research provides you the full spectrum of services related to market research, and corroborate with the clients to increase the revenue stream, and address process gaps.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@magnifierresearch.comWeb: http://www.magnifierresearch.com

See more here:
Global Cell Sorting Market 2020 Industry Analysis by Manufacturers, Type, Application, End-User and Forecast 2025 - Bandera County Courier

Read More...

Stem Cell Therapy Market Overview by 2026: Verified Market Research – Cole of Duty

Saturday, April 25th, 2020

Allosource

Global Stem Cell Therapy Market Segmentation

This market was divided into types, applications and regions. The growth of each segment provides an accurate calculation and forecast of sales by type and application in terms of volume and value for the period between 2020 and 2026. This analysis can help you develop your business by targeting niche markets. Market share data are available at global and regional levels. The regions covered by the report are North America, Europe, the Asia-Pacific region, the Middle East, and Africa and Latin America. Research analysts understand the competitive forces and provide competitive analysis for each competitor separately.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24113&utm_source=COD&utm_medium=002

Global Stem Cell Therapy Market Regions and Countries Level Analysis

The regional analysis is a very complete part of this report. This segmentation highlights Stem Cell Therapy sales at regional and national levels. This data provides a detailed and accurate analysis of volume by country and an analysis of market size by region of the world market.

The report provides an in-depth assessment of growth and other aspects of the market in key countries such as the United States, Canada, Mexico, Germany, France, the United Kingdom, Russia and the United States Italy, China, Japan, South Korea, India, Australia, Brazil and Saudi Arabia. The chapter on the competitive landscape of the global market report contains important information on market participants such as business overview, total sales (financial data), market potential, global presence, Stem Cell Therapy sales and earnings, market share, prices, production locations and facilities, products offered and applied strategies. This study provides Stem Cell Therapy sales, revenue, and market share for each player covered in this report for a period between 2016 and 2020.

Why choose us:

We offer state of the art critical reports with accurate information about the future of the market.

Our reports have been evaluated by some industry experts in the market, which makes them beneficial for the company to maximize their return on investment.

We provide a full graphical representation of information, strategic recommendations and analysis tool results to provide a sophisticated landscape and highlight key market players. This detailed market assessment will help the company increase its efficiency.

The dynamics of supply and demand shown in the report offer a 360-degree view of the market.

Our report helps readers decipher the current and future constraints of the Stem Cell Therapy market and formulate optimal business strategies to maximize market growth.

Table of Contents:

Study Coverage: It includes study objectives, years considered for the research study, growth rate and Stem Cell Therapy market size of type and application segments, key manufacturers covered, product scope, and highlights of segmental analysis.

Executive Summary: In this section, the report focuses on analysis of macroscopic indicators, market issues, drivers, and trends, competitive landscape, CAGR of the global Stem Cell Therapy market, and global production. Under the global production chapter, the authors of the report have included market pricing and trends, global capacity, global production, and global revenue forecasts.

Stem Cell Therapy Market Size by Manufacturer: Here, the report concentrates on revenue and production shares of manufacturers for all the years of the forecast period. It also focuses on price by manufacturer and expansion plans and mergers and acquisitions of companies.

Production by Region: It shows how the revenue and production in the global market are distributed among different regions. Each regional market is extensively studied here on the basis of import and export, key players, revenue, and production.

Complete Report is Available @ https://www.verifiedmarketresearch.com/product/Stem-Cell-Therapy-Market/?utm_source=COD&utm_medium=002

We also offer customization on reports based on specific client requirement:

1- Free country level analysis for any 5 countries of your choice.

2- Free Competitive analysis of any market players.

3- Free 40 analyst hours to cover any other data points

About us:

Verified market research partners with the customer and offer an insight into strategic and growth analyzes, Data necessary to achieve corporate goals and objectives. Our core values are trust, integrity and authenticity for our customers.

Analysts with a high level of expertise in data collection and governance use industrial techniques to collect and analyze data in all phases. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research reports.

Contact us:

Mr. Edwyne FernandesCall: +1 (650) 781 4080Email: [emailprotected]

Tags: Stem Cell Therapy Market Size, Stem Cell Therapy Market Trends, Stem Cell Therapy Market Forecast, Stem Cell Therapy Market Growth, Stem Cell Therapy Market Analysis

Continue reading here:
Stem Cell Therapy Market Overview by 2026: Verified Market Research - Cole of Duty

Read More...

Cover Corona Outbreak: Hematologic Malignancies Market is expected to grow at a CAGR of xx% during the forecast period from 2019-2025 – Cole of Duty

Saturday, April 25th, 2020

Hematologic Malignancies MarketLatest Research Report 2020:

The Hematologic Malignancies report provides an independent information about the Hematologic Malignancies industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porters five force analysis, and key companies

Download Premium Sample Copy Of This Report:Download FREE Sample PDF!

In this report, our team offers a thorough investigation of Hematologic Malignancies Market, SWOT examination of the most prominent players right now. Alongside an industrial chain, market measurements regarding revenue, sales, value, capacity, regional market examination, section insightful information, and market forecast are offered in the full investigation, and so forth.

Scope of Hematologic Malignancies Market: Products in the Hematologic Malignancies classification furnish clients with assets to get ready for tests, tests, and evaluations.

Major Company Profiles Covered in This Report

Pfizer, Inc., F. Hoffmann-LA Roche ltd, Sanofi-Aventis, Bristol-Myers Squibb Company, AbbVie, Inc., Novartis AG, GlaxoSmithKline PLC, Celgene Corporation, Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company limited,

Hematologic Malignancies Market Report Covers the Following Segments:<

Market segment by Type, the product can be split into

Leukemia, Lymphoma, Multiple Myeloma, Others,

Market segment by Application, split into

Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, Others,

Market segment by Regions/Countries, this report covers

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

North America

Europe

Asia-Pacific

South America

Center East and Africa

United States, Canada and Mexico

Germany, France, UK, Russia and Italy

China, Japan, Korea, India and Southeast Asia

Brazil, Argentina, Colombia

Saudi Arabia, UAE, Egypt, Nigeria and South Africa

Market Overview:The report begins with this section where product overview and highlights of product and application segments of the global Hematologic Malignancies Market are provided. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

Competition by Company:Here, the competition in the Worldwide Hematologic Malignancies Market is analyzed, By price, revenue, sales, and market share by company, market rate, competitive situations Landscape, and latest trends, merger, expansion, acquisition, and market shares of top companies.

Company Profiles and Sales Data:As the name suggests, this section gives the sales data of key players of the global Hematologic Malignancies Market as well as some useful information on their business. It talks about the gross margin, price, revenue, products, and their specifications, type, applications, competitors, manufacturing base, and the main business of key players operating in the global Hematologic Malignancies Market.

Market Status and Outlook by Region:In this section, the report discusses about gross margin, sales, revenue, production, market share, CAGR, and market size by region. Here, the global Hematologic Malignancies Market is deeply analyzed on the basis of regions and countries such as North America, Europe, China, India, Japan, and the MEA.

Application or End User:This section of the research study shows how different end-user/application segments contribute to the global Hematologic Malignancies Market.

Market Forecast:Here, the report offers a complete forecast of the global Hematologic Malignancies Market by product, application, and region. It also offers global sales and revenue forecast for all years of the forecast period.

Research Findings and Conclusion:This is one of the last sections of the report where the findings of the analysts and the conclusion of the research study are provided.

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Read the original:
Cover Corona Outbreak: Hematologic Malignancies Market is expected to grow at a CAGR of xx% during the forecast period from 2019-2025 - Cole of Duty

Read More...

Global IT Outsourcing Managed Service Market 2020: COVID 19 Breakdown Impact, Industry Analysis, Players, Type, Applications, Size, Share, Growth,…

Saturday, April 25th, 2020

In Global IT Outsourcing Managed Service Market Research Report, the study analysis was given on a worldwide scale, for instance, present and traditional IT Outsourcing Managed Service growth analysis, competitive analysis, and also the growth prospects of the central regions. The report gives an exhaustive investigation of this market provides an analysis of the industry trends in each of the sub-segments, from sales, revenue and consumption. A quantitative and qualitative analysis of the main players in Global and country level is introduced, from the perspective of sales, revenue and price.

Request a sample of IT Outsourcing Managed Service Market report @https://martresearch.com/contact/request-sample/5/32559

Snapshot:The global IT Outsourcing Managed Service market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of IT Outsourcing Managed Service by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage(Market Size & Forecast, Major Company of Product Type etc.):

IT ConsultingEquipment And SoftwareNetwork SystemOthers

Company Coverage(Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

IBMAccentureWiproCognizantDXC TechnologiesHCLHPInfosysCapgeminiNTT DataCGISAP

Application Coverage(Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Traditional IndustryHigh TechOthers

Region Coverage(Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)Europe (Germany, U.K., France, Italy, Russia, Spain etc.)Asia-Pacific (China, India, Japan, Southeast Asia etc.)South America (Brazil, Argentina etc.)Middle East & Africa (Saudi Arabia, South Africa etc.)

At the upcoming section, this report discusses industrial policy, economic environment, in addition cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.

Buy The Report @https://martresearch.com/paymentform/5/32559/Single_User

Major Point of TOC:

Table of Content1 Industry Overview2 Industry Environment (PEST Analysis)3 IT Outsourcing Managed Service Market by Type4 Major Companies List5 Market Competition6 Demand by End Market7 Region Operation8 Marketing & Price9 Research Conclusion

About us:Research is and will always be the key to success and growth for any industry. Most organizations invest a major chunk of their resources viz. time, money and manpower in research to achieve new breakthroughs in their businesses. The outcome might not always be as expected thereby arising the need for precise, factual and high-quality data backing your research. This is where MART RESEARCH steps in and caters its expertise in the domain of market research reports to industries across varied sectors.

Contact Us:

Mart Research[emailprotected]+1-857-300-1122

Link:
Global IT Outsourcing Managed Service Market 2020: COVID 19 Breakdown Impact, Industry Analysis, Players, Type, Applications, Size, Share, Growth,...

Read More...

Cell Isolation/Cell Separation Market 2020: Opportunities in Grooming Regions Thermo Fisher Scientific, Merck Millipore, Beckman Coulter and Others -…

Saturday, April 25th, 2020

Futuristic Reports, The growth and development of Global Cell Isolation/Cell Separation Market Report 2020 by Players, Regions, Type, and Application, forecast to 2026 provides industry analysis and forecast from 2020-2026. Global Cell Isolation/Cell Separation Market analysis delivers important insights and provides a competitive and useful advantage to the pursuers. Cell Isolation/Cell Separation processes, economic growth is analyzed as well. The data chart is also backed up by using statistical tools.

Simultaneously, we classify different Cell Isolation/Cell Separation markets based on their definitions. Downstream consumers and upstream materials scrutiny are also carried out. Each segment includes an in-depth explanation of the factors that are useful to drive and restrain it.

Key Players Mentioned in the study are Thermo Fisher Scientific, Merck Millipore, Beckman Coulter, Stemcell Technologies, Pluriselect Life Science, Miltenyi Biotec, GE Healthcare, BD Bioscience, Terumo BCT

For Better Understanding, Download FREE Sample Copy of Cell Isolation/Cell Separation Market Report @ https://www.futuristicreports.com/request-sample/3907

Key Issues Addressed by Cell Isolation/Cell Separation Market: It is very significant to have Cell Isolation/Cell Separation segmentation analysis to figure out the essential factors of growth and development of the market in a particular sector. The Cell Isolation/Cell Separation report offers well summarized and reliable information about every segment of growth, development, production, demand, types, application of the specific product which will be useful for players to focus and highlight on.

Businesses Segmentation of Cell Isolation/Cell Separation Market:

On the basis on the applications, this report focuses on the status and Cell Isolation/Cell Separation outlook for major applications/end users, sales volume, and growth rate for each application, including-

Biotechnology Research Center Hospital Others

On the basis of types/products, this Cell Isolation/Cell Separation report displays the revenue (Million USD), product price, market share, and growth rate of each type, split into-

Instrument Reagent Others

Grab Best Discount on Cell Isolation/Cell Separation Market Research Report [Single User | Multi User | Corporate Users] @ https://www.futuristicreports.com/check-discount/3907

NOTE: Our team is studying Covid-19 impact analysis on various industry verticals and Country Level impact for a better analysis of markets and industries. The 2020 latest edition of this report is entitled to provide additional commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation.

OR

You just drop an Email to:[emailprotected] us if you are looking for any Economical shift towards the New Normal on any Country or Industry Verticals.

Cell Isolation/Cell Separation Market Regional Analysis Includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (the United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.)

Cell Isolation/Cell Separation Insights that Study is going to provide:

Gain perceptive study of this current Cell Isolation/Cell Separation sector and also possess a comprehension of the industry; Describe the Cell Isolation/Cell Separation advancements, key issues, and methods to moderate the advancement threats; Competitors In this chapter, leading players are studied with respect to their company profile, product portfolio, capacity, price, cost, and revenue. A separate chapter on Cell Isolation/Cell Separation market structure to gain insights on Leaders confrontational towards market [Merger and Acquisition / Recent Investment and Key Developments] Patent Analysis** Number of patents filed in recent years.

Table of Content:

Global Cell Isolation/Cell Separation Market Size, Status and Forecast 20261. Market Introduction and Market Overview2. Industry Chain Analysis3. Cell Isolation/Cell Separation Market, by Type4. Cell Isolation/Cell Separation Market, by Application5. Production, Value ($) by Regions6. Production, Consumption, Export, Import by Regions (2016-2020)7. Market Status and SWOT Analysis by Regions (Sales Point)8. Competitive Landscape9. Analysis and Forecast by Type and Application10. Channel Analysis11. New Project Feasibility Analysis12. Market Forecast 2020-202613. Conclusion

Enquire More Before Buying @ https://www.futuristicreports.com/send-an-enquiry/3907

For More Information Kindly Contact:

Futuristic ReportsTel: +1-408-520-9037Media Release:https://www.futuristicreports.com/press-releases

Follow us on Blogger @https://futuristicreports.blogspot.com/

See more here:
Cell Isolation/Cell Separation Market 2020: Opportunities in Grooming Regions Thermo Fisher Scientific, Merck Millipore, Beckman Coulter and Others -...

Read More...

Stem-cell therapy in Moscow attracting patients from West …

Monday, April 20th, 2020

Every three months, David Martin, a quadriplegic, returns to a small clinic here in the Russian capital for therapy he cannot legally get back home in Kalamazoo, Mich.: injections of stem cells taken from his own body, at a cost of $12,000 per visit.

MOSCOW Every three months, David Martin, a quadriplegic, returns to a small clinic here in the Russian capital for therapy he cannot legally get back home in Kalamazoo, Mich.: injections of stem cells taken from his own body, at a cost of $12,000 per visit.

Martins U.S. doctors have tried to dissuade him from believing any improvement in his condition could be the byproduct of stem-cell treatments, a therapy not yet approved in the United States. No scientific evidence has ever shown that such treatments can repair human spinal-cord injuries, experts say.

Yet Martin notices glints of progress a twinge of sensation in one of his curled, still hands, a faraway feel of something cold on his skin. He attributes it to the stem-cell treatments he has been getting in Moscow.

Its definitely unfortunate that the U.S. isnt doing this, said Martin, 36, paralyzed since a car accident in 2006. Its not an inexpensive venture, and its not easy on the body to have to travel this distance.

Martin is just one of a growing number of Americans and Europeans turning to Russia, China and other countries where the stem-cell industry operates unfettered and largely unregulated.

NeuroVita, the clinic Martin has been visiting since 2007, attracts paraplegics and quadriplegics from around the world and maintains a waiting list for overflow clientele. Elsewhere in the capital, chic beauty clinics rely on stem-cell therapy to beckon Moscows moneyed elite, pitching the treatments as a surefire answer to wrinkles and stretch marks.

What troubles critics is the rush in some countries to offer stem-cell therapy on the health-care market, the absence of governmental oversight associated with stem-cell treatments in those countries, and the lack of any proof that the treatments actually work. If patients feel improvement, experts say, its likely a placebo effect or the result of their bodys own healing mechanisms.

NeuroVita relies on adult stem cells taken from the patients own bone marrow, a type of stem cell widely regarded as having far less therapeutic potential than embryonic stem cells stem cells derived from human embryos.

About making money

While adult stem cells may be useful in treating cancer or brittle-bone disease, most experts think its impossible to turn blood-derived adult stem cells into nerve cells, and that anyone offering such treatments is not relying on peer-reviewed science.

I dont think theres much science to it, said Vladimir Smirnov, director of the Moscow Institute of Experimental Cardiology, a licensed Russian stem-cell researcher and a leading critic of clinics that sell stem-cell injections. Its all about making money.

The wonder of stem cells lies in their ability to reproduce and differentiate into whatever variety of tissue the body requires. Adult cells do not reproduce, but stem cells divide freely. Stem cells also tend to seek out damaged tissue, making them catalysts for restoration. In recent years, scientists have been encouraged by research that suggests stem-cell therapy could one day be applied to a wide array of disorders and injuries.

A recent study involving rats with Parkinsons disease showed that embryonic stem cells genetically altered to yield dopamine-producing neurons could be transplanted into the rats brains and improve motor function. Other studies have shown that adult stem cells injected into mice with damaged hearts can repopulate heart tissue with new heart-muscle cells.

Doctors have been relying for four decades on bone-marrow transplants that use adult stem-cell technology to treat cancers such as leukemia and lymphoma.

But the U.S. Food and Drug Administration (FDA) has yet to approve embryonic or adult stem-cell injections to treat other disorders. The FDA allows stem-cell clinical trials involving humans, but the research is carefully controlled and usually involves a small number of patients.

Elsewhere in the world, however, regulations governing stem-cell therapy are lax and usually poorly enforced.

In Russia, the Federal Health Inspection Service must approve a clinics use of stem-cell therapy. Several years ago, Russian authorities shut down more than 30 medical institutions illegally carrying out stem-cell treatments, but numerous clinics continue to sell the injections under the radar of regulators.

Clinical trials allowed

A Moscow clinic called Beauty Plaza has the governments permission to carry out adult stem-cell injections within the framework of clinical trials. The stem cells are taken from the patients fatty tissue. Usually, subjects of clinical trials do not pay for their treatments, but Beauty Plaza clients have to pay for theirs, says the clinics director, Alexander Teplyashin.

We can eradicate atherosclerosis symptoms, and we can cure diabetes Type 2, Teplyashin said confidently during an interview at his clinic. After the treatments, patients stop getting the flu. They become more energetic, more active.

According to its Web site, NeuroVita has governmental approval to offer adult stem-cell therapy to neurological patients. The clinics director, Andrei Bryukhovetsky, said NeuroVita has used stem-cell treatments on 200 patients since 2002, 70 percent of them foreign citizens and at least 30 patients from the United States.

Bryukhovetsky touts results that most experts would label as doubtful: A young man from Siberia paralyzed from the neck down now eats on his own, drinks tea, all within a year. For another patient with a spinal-cord injury in his neck, one injection was enough. After one day he began writing, Bryukhovetsky said.

How can we explain it? I dont know, Bryukhovetsky said. But it works.

The trouble with such anecdotal evidence, said Evan Snyder, a U.S. expert on stem-cell research, is that it lacks credibility. And the best environment to ensure that credibility, Snyder said, is a proper, well-controlled clinical trial.

Anecdotal evidence doesnt mean anything to me, said Snyder, a stem-cell researcher at the Burnham Institute in La Jolla, Calif. Im happy for the patient if he feels better. But one has to be cautious about what to attribute that improvement to.

Stem-cell treatments arent without risk, Snyder adds.

It could be a situation where the stem cells go to the wrong place in the body, or they are the wrong type of cells for a given region, he said. They could turn into cancer themselves, or cause neighboring cells to become cancerous.

It remains unclear when stem-cell technology will be ready for broader application in U.S. health care. Patients like Martin say they dont want to wait.

Patient sees progress

On a recent afternoon in a physical-therapy room at NeuroVita, Martin demonstrated what he believed was progress attributable to the stem-cell injections he received in his spine. He winced slightly as his hands, fastened to weight machine handles with leather straps, pulled back to lift 55 pounds. Before the treatments, he could lift just 2 pounds, he said.

Ive come a long way, Martin said. Seems like every time I come back from Russia, Ive gone up 5 or 10 pounds.

Martin, manager of an automotive component plant before the accident, spent $33,000 on an initial visit, for an overall cost of about $81,000 on five visits to NeuroVita since June 2007.

He believes hell need one more year of treatments.

If someone has the wherewithal to do something like that and it improves their psychological well-being, I wouldnt prevent them from doing it, said, Snyder the stem-cell researcher, as long as they recognized that the likelihood for improvement is minimal.

Follow this link:
Stem-cell therapy in Moscow attracting patients from West ...

Read More...

Stem Cell Umbilical Cord Blood Market 2020 Share Insights and Dynamics | Cells for Life, Cryolife, Cryo-Cell Cole Reports – Cole of Duty

Monday, April 20th, 2020

Futuristic Reports, The growth and development of Global Stem Cell Umbilical Cord Blood Market Report 2020 by Players, Regions, Type, and Application, forecast to 2026 provides industry analysis and forecast from 2020-2026. Global Stem Cell Umbilical Cord Blood Market analysis delivers important insights and provides a competitive and useful advantage to the pursuers. Stem Cell Umbilical Cord Blood processes, economic growth is analyzed as well. The data chart is also backed up by using statistical tools.

Simultaneously, we classify different Stem Cell Umbilical Cord Blood markets based on their definitions. Downstream consumers and upstream materials scrutiny are also carried out. Each segment includes an in-depth explanation of the factors that are useful to drive and restrain it.

Key Players Mentioned in the study are Cell Care, Cells for Life, Cryolife, Cryo-Cell, CBR (Cord Blood Registry), Stemlife, CELLTREE(CELLTREE), StemOne Biologicals, Healthbanks Biotech, Stemcyte Inc, Smart Cells, ViaCord, LifeCell, Cryosite, Cordlife

For Better Understanding, Download FREE Sample Copy of Stem Cell Umbilical Cord Blood Market Report @ https://www.futuristicreports.com/request-sample/39381

Key Issues Addressed by Stem Cell Umbilical Cord Blood Market: It is very significant to have Stem Cell Umbilical Cord Blood segmentation analysis to figure out the essential factors of growth and development of the market in a particular sector. The Stem Cell Umbilical Cord Blood report offers well summarized and reliable information about every segment of growth, development, production, demand, types, application of the specific product which will be useful for players to focus and highlight on.

Businesses Segmentation of Stem Cell Umbilical Cord Blood Market:

On the basis on the applications, this report focuses on the status and Stem Cell Umbilical Cord Blood outlook for major applications/end users, sales volume, and growth rate for each application, including-

Blood Disorders Cancers Immune Disorders Metabolic Disorders Others

On the basis of types/products, this Stem Cell Umbilical Cord Blood report displays the revenue (Million USD), product price, market share, and growth rate of each type, split into-

Allogeneic stem cell umbilical cord blood Autologous stem cell cord blood

Grab Best Discount on Stem Cell Umbilical Cord Blood Market Research Report [Single User | Multi User | Corporate Users] @ https://www.futuristicreports.com/check-discount/39381

NOTE: Our team is studying Covid-19 impact analysis on various industry verticals and Country Level impact for a better analysis of markets and industries. The 2020 latest edition of this report is entitled to provide additional commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation.

OR

You just drop an Email to: [emailprotected] us if you are looking for any Economical shift towards the New Normal on any Country or Industry Verticals.

Stem Cell Umbilical Cord Blood Market Regional Analysis Includes:

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) North America (the United States, Mexico, and Canada.) South America (Brazil etc.) The Middle East and Africa (GCC Countries and Egypt.)

Stem Cell Umbilical Cord Blood Insights that Study is going to provide:

Gain perceptive study of this current Stem Cell Umbilical Cord Blood sector and also possess a comprehension of the industry; Describe the Stem Cell Umbilical Cord Blood advancements, key issues, and methods to moderate the advancement threats; Competitors In this chapter, leading players are studied with respect to their company profile, product portfolio, capacity, price, cost, and revenue. A separate chapter on Stem Cell Umbilical Cord Blood market structure to gain insights on Leaders confrontational towards market [Merger and Acquisition / Recent Investment and Key Developments] Patent Analysis** Number of patents filed in recent years.

Table of Content:

Global Stem Cell Umbilical Cord Blood Market Size, Status and Forecast 20261. Market Introduction and Market Overview2. Industry Chain Analysis3. Stem Cell Umbilical Cord Blood Market, by Type4. Stem Cell Umbilical Cord Blood Market, by Application5. Production, Value ($) by Regions6. Production, Consumption, Export, Import by Regions (2016-2020)7. Market Status and SWOT Analysis by Regions (Sales Point)8. Competitive Landscape9. Analysis and Forecast by Type and Application10. Channel Analysis11. New Project Feasibility Analysis12. Market Forecast 2020-202613. Conclusion

Enquire More Before Buying @ https://www.futuristicreports.com/send-an-enquiry/39381

For More Information Kindly Contact:

Futuristic ReportsTel: +1-408-520-9037Media Release: https://www.futuristicreports.com/press-releases

Follow us on Blogger @ https://futuristicreports.blogspot.com/

See original here:
Stem Cell Umbilical Cord Blood Market 2020 Share Insights and Dynamics | Cells for Life, Cryolife, Cryo-Cell Cole Reports - Cole of Duty

Read More...

Astronomers observe the brightest supernova on record – Yahoo Lifestyle

Monday, April 20th, 2020

In 2016, astronomers spotted the brightest supernova ever observed. They watched as the supernova, named SN2016aps, continued to emit radiation for more than 1,000 days. Today, in a paper published in Nature, they describe how this extremely energetic supernova could help them understand the universes evolution and the formation of the most massive stars.

SN2016aps flared so brightly that it outshone its own galaxy, and over its long span, it emitted more light than any supernova on record, Matt Nicholl, the studys first author from the University of Birmingham in the United Kingdom, told Gizmodo. At five to 10 times the mass of a typical supernova, it was one of the largest stars ever seen to explode. The total mass of the object and the material it ejected before exploding could have been 50 to 100 times the mass of the Sun, Gizmodo notes.

SN2016aps likely occurred around 10 billion years after the Big Bang. Now, with data from this supernova and more powerful telescopes like the James Webb Space Telescope, the researchers hope to find similar events even further back in the universes history, when they may have been more common.

See more here:
Astronomers observe the brightest supernova on record - Yahoo Lifestyle

Read More...

Roma woman tells of her ‘life-changing’ MS treatment – Chronicle

Tuesday, April 7th, 2020

THERES a 70 per cent chance youre going to get a mum without MS for the first time.

Those were the words Amanda Weyman-Jones told her daughter before they hopped on a plane, in a last ditch-attempt for Amanda to take her future back.

In January, Amanda and daughter Chloe travelled halfway across the globe to Moscow, Russia for a life changing and experimental treatment in hopes it would effectively stop her three decade battle with multiple sclerosis in its tracks.

The trip was made possible with the support from the Roma community who banded together to help Amanda raise $80,000 to pay for the treatment only available in the Russian capital.

And according to Amanda, she has already seen a massive improvement with her condition.

Im walking and I would say I have improved 70 per cent already, and its only expected to get better as time goes on, the 58-year-old mother of six said.

They say that the treatment gives you an 80 per cent (chance) of curing your MS and at the moment, I feel like Im in that 80 per cent Im feeling really good about my chances.

Amanda underwent an experimental procedure called Autologous haematopoietic stem cell transplant (AHSCT) treatment, which rebuilds the patients immune system.

Seven weeks on and Amanda says she feels like a new person, and has been walking around the football field everyday, which she states is a miracle as she couldnt even walk to the field before the treatment.

Ever since returning to Roma from Russia in February, all she has wanted to do is shout from the rooftops that others living with MS can also have their lives changed.

I heard about a man on a property in Blackall with MS and hes young so I want him to know he doesnt have to have this disease, you can get better, Mrs Weyman-Jones said.

This treatment gives you that infinity with people. Its life saving stuff.

Amandas brother Hayward and sister Diana were both diagnosed with MS too; Hayward died last year, and Diana is now in a wheelchair.

All too familiar with the devastating effects of MS, Amanda is determined to not become a burden on her loved ones.

Amanda who has Primary Progressive MS was given an Expanded Disability Status Scale (EDSS) score of 4.5 which notes a limited walking mobility to approximately 300m without aide prior to treatment. With no action taken, she would probably have continued to progress until she was wheelchair bound. The EDSS is scored zero to 10, with 10 marking a person has died from MS.

Now, with more improvements expected to continue in the next six to 12 months, Amanda is hopeful her quality of life will improve and once her immunity has built up, to continue working at the family-owned-and-run Overlander Motel.

I will be forever grateful to Dr Frederinco, the brilliant medical team in Russia, Roma, its local businesses and the wider community for blessing me with a new life, Amanda said.

Through the generosity and support by all, I have realised how lucky I am to be surrounded by such a caring community.

Amanda said she knew that while there is a long road ahead of her, every passing day she is more feeling more hopeful.

I was told that recovery can be like a rollercoaster, so I will accept the bad days and make sure I remember the good, she said.

My walking is slowly getting safer and less hazardous to myself . and to all other pedestrians. Every morning I wake up, knowing that every days a better day.

I am a new person, it is just a miracle.

Stats about MS

With MS Queensland aware of nearly 4000 people living with Multiple Sclerosis in Queensland and over 25,600 people in Australia living with the neurological condition.

Most people with MS in Australia experience their first symptoms between 20 and 40 years of age, with about three quarters of people living with MS, female.

MS is not considered a classic genetic disease in that there is not one single gene that causes the condition. Rather, there are more than 200 different known genetic factors which contribute to the risk of developing MS. It has been estimated that genes may account for around half of the risk for MS, and those with a family history of MS are at greater risk than the general population. Even so, the majority of people with a family member with MS will not develop the disease so genes on their own are not enough.

MS is caused by a complex interaction between a persons genetics and environment factors.

Autologous haematopoietic stem cell transplant (AHSCT) is an immunosuppressive chemotherapy treatment combined with reinfusion of blood stem cells to help rebuild the immune system.

AHSCT has been used for decades for the treatment of blood cancers. However in the past ten or so years a number of international observational studies of several hundred patients have been published with some patients being followed for five to eight years.

The treatment consisted of four days of stimulation before the stem cells were collected and then Amanda was pumped full of high dose chemotherapy.

Amanda then had a rest day, and on January 29, her harvested stem cells were returned to her MS ravaged body, signalling the rebirth of her immune system with no memory of MS.

After that she was given daily steroid infusions and was put into isolation for six nights before one final dose of chemotherapy.

Response from MS Queensland about the treatment

CEO of MS Queensland Zane Ali said MS Queensland and MS Research Australia are continuing to support Australian research in the use of AHSCT to treat multiple sclerosis.

Rigorous evidence for the efficacy and safety of AHSCT in relation to other MS therapies, and the most appropriate circumstances for its use, is required for Australian hospitals and clinicians to provide this intervention with equity and with greater confidence in the potential outcomes, he said.

Australian hospitals and doctors are likely to recommend AHSCT as a possible treatment only if the other approved MS therapies are not working for an individual with MS or cannot be used in an individual for other reasons.

Despite Amandas MRI revealing her Central Nervous System was so progressed (with 35 lesions or more on the spine), she met the criteria for the treatment because of her mobility.

You have to be at a very healthy besides having MS, patients are tested from head to toe when they first arrive in hospital to ensure that they dont have any cancers or illnesses that could effect the viability of the treatment, said daughter Chloe.

The doctor was surprised after he saw how mobile mum still was considering the damage that he saw in her brain.

People arent accepted all of the time, some are told before they go and some are only told after all of the testing is completed in Moscow, then they are then sent home. International studies also suggest AHSCT does not halt or reverse progressive forms of the disease, and is therefore unlikely that

AHSCT would be recommended as a treatment for patients with secondary progressive or primary progressive MS.

Currently the treatment is provided in Australia through two observational clinical trials, at St Vincents, Sydney and Austin Health, Melbourne and by a small number of other centres on a case-by-case basis.

These centres have strict eligibility requirements that have been set by the hospital ethics committees and may only apply to limited numbers of patients with MS, Mr Ali said.

It is for this reason patients need to be referred to these centres by a neurologist, who can provide a detailed clinical history and MRI findings, Mr Ali said.

Mr Ali said that data from the large European Bone Marrow Transplant Registry suggests that in approximately 55 per cent of people with MS, treated with a range of different chemotherapy regimens, at three years of follow-up, inflammatory disease is halted with no evidence during the follow-up period of relapses, active brain lesions or disability progression.

After five years approximately 45 per cent of people remain progression free.

This case series included patients with both relapsing remitting and progressive disease, he said.

Other smaller studies have shown similar results, with remission of disease seen in these studies in at least 63 per cent of patients followed for a minimum of three years.

Most studies also show that the risk of disease activity returning gradually increases over longer periods of follow-up.

Mr Ali said in some but not all, of the people with MS who respond to AHSCT, some reversal of disability has been noted in some studies.

Other patients may continue to experience disease activity and disability progression (worsening) despite treatment with AHSCT, he said.

In people with progressive forms of MS or relapsing remitting MS of longer duration, the benefits of the procedure have been much less clear and accumulation of disability usually continues.

Amanda said they chose Moscow for the treatment because despite other countries offering the experimental procedure, after thorough research they found Russia had the highest rate of treatment success.

They accept advanced progressive MS where most of the other clinics offering it only treat relapsing remitting MS, she said.

I was still on my feet (only just) but people went over in wheelchairs, walkers, walking sticks and many were older than me.

For Chloe, who is training to become a nurse and who spent every spare moment researching AHSCT treatment said while they mostly compared the options available in Mexico and Russia, Russia stood out to them because it was cheaper and they had more experience.

One of the major influencing factors was that in Mexico patients stayed in a complex with they carer and in Russia patients stayed in a hospital, so we felt more reassured knowing that mum would have 24 hour care provided to her at the touch of a buzzer, she said.

Great lengths of a loving daughter

Although Amanda has lived with MS for 34 years, she feels like she is one of the lucky ones.

None of this would have been possible without Chloe. Her drive and determination surprises me every day, she said.

Researching, booking, fundraising and organising the whole trip, proves to me that I am the luckiest mum on earth.

Chloe was the driving force behind the push for treatment and the GoFundMe campaign which raised over half the $80,000 goal was with her mum every step of the journey.

I have found spending a month in Russia very interesting, the first couple of weeks for easy, but after that I just wanted to come home to Australia, the 19-year-old said.

Every day I would go and visit Mum in the morning and stay there with her until dark and then head on back to the hotel, I basically just did that every day.

I made some great friends with some other patients carers and so often we would catch up at the end of the day to recuperate and support each other.

Although the month spent away from her loved ones began to take its toll, Chloe has high hopes for the future.

It was very draining being over there, I felt like I wasnt doing much but I was just always so tired, she said.

Its amazing to see how quickly mum is healing after the treatment, but it will take some time to see what the true outcome for her is going to be.

In the end, we dont know what the future holds for mum and her MS, we are just thinking positively and hope that we see improvements over the next 12 months.

We feel very lucky that we had the opportunity to go over and are now advocating for other people to have the treatment as well.

Chloe and Amanda Weyman-Jones sightseeing in Moscow before the treatment began.

During the treatment.

Amanda Weyman-Jones with Greta and Theresa who were also going through the treatment.

Read the original here:
Roma woman tells of her 'life-changing' MS treatment - Chronicle

Read More...

Leukapheresis Market Is Booming Worldwide | Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc. -…

Tuesday, April 7th, 2020

The Leukapheresis market research report is required to show a gigantic development inside the upcoming years. The investigators likewise have dissected downsides with on-going Organic Semiconductor patterns and in this manner the open doors that are giving to the expanded development of the business. The report gives the viewpoint of this aggressive scene of worldwide markets. The report passes points of interest that started from the examination of the focused on market

leukapheresis market is expected to rise from its initial estimated value of USD 19.9 million in 2018 to an estimated value of USD 36.1 million by 2026 registering a CAGR of 7.7% in the forecast period of 2019-2026. Leukapheresis is a procedure used for separating white blood cells from a sample of blood. It can be performed to reduce the count of very high white blood cell, to attain cells for various research purposes and to obtain autologous blood cells for further transplant back into patient. It is a type of apheresis, used for separating out a particular constituent of blood and to return the remaining part back to the circulation.

Leukapheresis Market 2027 Top Players (Market Analysis, Opportunities, Demand, Forecasting)

Click HERE To get SAMPLE COPY OF THIS REPORT (Including Full TOC, Table & Figures) [emailprotected]https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-leukapheresis-market

The titled segments and sub-section of the market are illuminated below:

By Type (Leukapheresis Devices, Leukapheresis Disposables),

Application (Research Applications, Therapeutic Applications),

End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Transfusion Centers),

Geographical Insights:

In-depth qualitative analyses include identification and investigation of the following aspects:

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global extended reality market in every aspect of the classification from perspectives of Technology, Component, Device Type, Industry Vertical, End-user, and Region.

Competitive Analysis: Leukapheresis Market

The global leukapheresis market is highly fragmented and the major players have used different strategies such as mergers, partnerships, expansions, innovative product launches, agreements, joint ventures, acquisitions and others to increase their footprints in this market. The report includes market shares of leukapheresis market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Leukapheresis Market competitive landscapes provides details by topmost Key Players like

Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Macopharma, Fresenius SE & Co. KGaA, HemaCare, Caltag Medsystem Ltd, AllCells, StemExpress, PPA, Key Biologics LLC, ZenBio Inc., Precision for Medicine Inc., BioIVT, Digital Pharmacist Inc., Lmb Technologie GmbH, Grifols, S.A, Bioelettronica and Kaneka Pharma Europe NV.

Browse in-depth TOC on Global Leukapheresis Market60- Tables220- Figures350 Pages

The Study Objectives of the Global Leukapheresis Market Research Report are:

Table of Content:

Chapter One: Global Leukapheresis Industry Market Research Report

Chapter Two: Industry Chain Analysis

Chapter Three: Global Leukapheresis Market, by Type

Chapter Four: Leukapheresis Market, by Application

Chapter Five: Global Leukapheresis Production, Value ($) by Region (2015-2020)

Chapter Six: Global Leukapheresis Production, Consumption, Export, Import by Regions (2015-2020)

Chapter Seven: Global Leukapheresis Market Status and SWOT Analysis by Regions

Chapter Eight: Competitive Landscape

Chapter Nine: Global Leukapheresis Market Analysis and Forecast by Type and Application

Chapter Ten: Leukapheresis Market Analysis and Forecast by Region

Chapter Eleven: New Project Feasibility Analysis

Chapter Twelve: Research Finding and Conclusion

Chapter Thirteen: Appendix

Read More: https://www.databridgemarketresearch.com/toc/?dbmr=global-leukapheresis-market

For each of the aforementioned regions and countries, detailed analysis and data for annual revenue (demand and production) are available for 2020-2027. The breakdown of all regional markets by country and the key national markets by Technology, Component, and Industry Vertical over the forecast years are also included.

How will this Market Intelligence Report Benefit You?

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:[emailprotected]

Read the original:
Leukapheresis Market Is Booming Worldwide | Asahi Kasei Medical Co. Ltd, Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc. -...

Read More...

The New New Math: Inside the Russian School of Mathematics – Boston magazine

Monday, April 6th, 2020

K-12 Education

It touts itself as the key to helping your child get a leg up at school and presumably into college. Is this just the latest case of wealthy suburbanites keeping up with the Joneses, or has a Russian woman in Newton figured out a better way to teach to American kids?

Russian School of Mathematics cofounder Inessa Rifkin started teaching kids extra math at her dining room table in Newton more than 20 years ago. Today, the program has 40,000 students in 53 schools in 12 states, Washington, DC, and Canada, in addition to a booming online program. / Photo by Jason Grow

On a January afternoon at the Russian School of Mathematics headquarters, a 6,500-square-foot bilevel brick building in a Newton corporate office park, Inessa Rifkin leads 15 excitable third and fourth graders through a lesson on graphs. She is in her sixties and chic in a blue-gray tunic over a crisp white button-down, skinny black pants, and a Tiffany-style silver pearl necklace. When she asks a question, her Russian accent unflinching, more than half of the students put their hands in the air. Not a single one has a cell phone on his or her desk. No ones staring into space.

About halfway through the two-hour class she asks, Quiz or break? The group is unanimous in its decision: Quiz it is!

For Rifkin, there are two reasons to celebrate: Not only have the kids willingly chosen a quiz, but just before class began shed learned that the Russian School of Mathematicsthe extracurricular K12 program she cofounded with fellow Soviet Union expat Irina Khavinson in Newton 22 years agohad surpassed 40,000 students. RSM has 53 locations in 12 states, Washington, DC, and Canada. Online classes already have students from 24 countries, and are growing faster than Rifkins son, Ilya, who is the CEO, can find qualified teachers to teach them.

As the schools birthplacebut also as a particular hotbed of do-more, get-ahead parentingMassachusetts is ground zero for Russian Math. Inessa Rifkin estimates that one in four elementary students in Lexington is enrolled in her after-school program; the majority of kids start in second grade and continue through at least eighth, though many go all the way through high school. I remember we couldnt believe it when we got 40 students that first year, she says. Back then, she held classes around her dining room table, and the neighbors complained about the lines of cars coming and going. These days, RSM employs a traffic cop to help keep order during pickup and drop-off at the schools flagship location, which can accommodate several hundred kids at any given time. We never even considered ourselves businesswomen, Rifkin says of herself and Khavinson, acknowledging that they didnt have a proper business plan until 2009, when Ilya quit his job at a Manhattan hedge fund to join the company at his mothers urging. And in this business plan, he wrote we would reach 10,000 students, Rifkin says. I laughed. Ten thousand students? From where?

A decade later, Russian Math is nothing short of a phenomenon. Rifkin and Khavinson have been approached by eager VCs several times over the past 20 years to invest or buy them out and have turned down every offer. Parents of students in Russian Math, meanwhile, note with pride that their kids are two or three years ahead of their peers in math at school, and the company boasts of students remarkable scores on standardized tests (a 774 average math score for juniors who take the SAT) and high GPAs in school. The lobby at HQ displays photos of alumni alongside their recent college acceptances: Brown, Dartmouth, MIT, Georgetown.

Still, not everyone thinks the program is the best thing thats happened to math education since flashcards. Critics say it has questionable academic value to children and is focused more on accelerating students than deepening their understanding of the material. Whats more, theres growing concern that the significant proportion of students enrolled in Russian Math in some Boston suburbs is having a negative effect on the learning environment inside regular school classrooms. Some see RSM as less of a mathematical miracle and more of an example of savvy marketing colliding headlong into suburban parental panic. In a prior age, if your child was having trouble in math, youd hire a tutor, if you had the money, says Jon Star, an educational psychologist at Harvard who researches math education. But all these kids who are going to Russian Math arent going there because theyre having trouble in math. Theyre going there because the public school is not going fast enough for what parents perceive their child needs. So its just a very different set of motivations.

Such behavior can put even more pressure on kids who are already feeling unprecedented levels of anxietyand on parents to keep up with one another, either for perception or for something to talk about at dinner parties. Newton mother of three Marcela Almeida, whose oldest child started at RSM in third grade, her middle child in first, and her youngest in kindergarten, found herself smack dab in the middle of the rapidly accelerating suburban mathematical arms race. She says she enrolled her kids in RSM even before shed decided there was anything particularly wrong with the education they were getting for free at the public schools. I felt a tremendous pressure from our community to send our kids to RSM, she says. It appears as though attending RSM is the norm where we live, so I didnt want them to be behind.

Irina Khavinson worked as a math teacher for 15 years in St. Petersburg before teaming up with Rifkin to found the Russian School of Mathematics. / Photo by Jason Grow

Rifkin came to the United States from the Soviet Union with her husband, Victor, and their two kids, Ilya and Masha, with eight suitcases and $90 in 1988. She got a job as a mechanical engineer at Kronos, a maker of labor-management software. Ilya was in eighth grade when Rifkin says she started to question his motivation in school. His grades were fine, but not great; she assumed he was being lazy. So I looked at what he was learning, she says. The math wasnt up to my standards. He did not know things I thought he should know by then. The lessons lacked cohesive flow; they were disconnected from one to the next and the process focused more on getting to the correct answer than understanding how to get there. No wonder Ilya wasnt motivated, she thought, and of course he and his friends all hated maththe material was prescribed, rote, and very dull. Rifkin started talking to other parents. Slowly, I came to the realization that its not that hes lazy, she says. He takes advantage of everything thats offered to him. But not much is offered to him.

Rifkin started tutoring her son and some of his friends after work using lessons she remembered from an elite mathematics school that shed attended in Minsk. The kids seemed to respond, and she began to think of ways to offer lessons to even more students, envisioning a structured program with teachers who would demand respect from their students and a math curriculum that would make learning funand effective. Not something where someone comes to your house and your child feels like, My parents pay you money so you do what I tell you to do, which could not be more American, she says.

Her first step: Find a teacher. I started to ask around, Who knows good teachers from back in the Union? she says. In response, a few people told her that somebody told them that somebody had mentioned a woman named Irina. Then 47, Khavinson had been a math teacher for 15 years in St. Petersburg, then known as Leningrad. In Boston, she was working as an accountant and tutoring kids on the side, using a mix of Russian textbooks and lessons shed developed on her own.

In December 1997, not long after teaming up, Khavinson and Rifkin advertised a meeting at Temple Beth Elohim in Wellesley to talk about the state of their childrens math education. Six hundred people showed up, mostly Russian-Jewish immigrants. Rifkin stood before them and presented her idea for the Russian School of Mathematics. She talked about building a community based on a common need, a place where kids could learn math and play together, and parents could get acquainted with one another. She didnt have to explain to fellow Russians why math was important. To them, Rifkin says, math is what puts minds in order. Whats more, for immigrant families, STEM is considered a lifeline and the pathway to success in the United States. I said, We know what good mathematics is. Lets try to do that here for our kids, she recalls. One Newton mom, Olga Dadasheva, stood up and said she recognized the problem, but asked what made Rifkin think she was the one who could solve it. And I said to her, Rifkin recalls, You pretty much dont have any other choice but to let me try.

Dadasheva, who arrived in the U.S. from Moscow in 1989 and was working as a software developer, had been looking for math tutoring for her daughter, who was 12 at the time. Its easy to criticize American education in general, Dadasheva says now. But Russians in particular have this experience where it has to be hard at school. You have to work very hard and get great marks. And that was missing in American schools, where it was more like, If you can do it, thats great. If you cannot do it, thats great, do it tomorrow.

That night at the temple in Wellesley, Rifkin and Khavinson convinced 60 students to commit, all children of Russian immigrants. Says Rifkin: It was less a business than a movement.

Once RSM students (and their peers) started to see the edge they had over the other kids in school, and the confidence that resulted, more kept comingRussian students, but also children of Chinese and Indian and European immigrants, too. By February 1998, Rifkin had quit her job at Kronos, and by September of that year, RSM had enrolled 150 students and moved to its first commercial location on Beacon Place in Newton, a two-room space on the second floor, over a hair salon. In 1999, Rifkin took out a home equity loan to buy a small white house with blue shutters on busy Centre Street, onto which her husband installed a large sign that read, The Russian School of Mathematics. It was all the advertising they needed, Rifkin says. In no time, the first Americans started showing up.

Biotech entrepreneur Heidi Wyle was one of them. She and her husband had moved to Weston for the good public schools, she says, but teachers were not teaching math the way she thought they should. We used to joke that in the Weston schools, it was like, No child allowed ahead, says Wyle, whose children are now grown and in their twenties. They were happy to handle the kids who needed help, but they didnt want these kids who were really bright.

Wyle was instrumental in introducing RSM to her circle of high-powered, highly educated friends, which included several parents who were professors at Harvard and MIT. But a 2001 article that ran on the front page of the Boston Globe, A Russian Solution to a U.S. Problem, was the key to drawing in American families en masse, Rifkin says. The writer basically drove by on a Sunday morning and saw these kids playing outside the house, she recalls. He stopped and asked a very cute kid, What are you doing here? And the kid said, Im studying math. He said, Youre studying math on a Sunday morning? Why? And the kid said, Because I want to get smart and go to MIT. The morning after the story ran, Rifkin arrived at the little house on Centre Street to find a line out the door.

Teacher Irena Burmistrovich instructs a classroom full of engaged students. / Photo by Jason Grow

From the start, Rifkin and Khavinson developed the RSM curriculum in-house, taking some of what Rifkin had used to teach Ilya and some of what Khavinson had used with her students, and then put the first round of tuition payments they received into further developing the coursework. They relied largely on the network of parents gathered that night at Temple Beth Elohim to find Russian migrs, many of whom worked in academia, to help create lesson plans that emphasized critical thinking and reasoning over memorization. Advanced concepts, such as algebra, were introduced as early as first grade, using age-appropriate approaches and lots of visuals, because according to Rifkin and Khavinson, studies show that kids who learn algebra at an early age have better cognitive development overall. They encourage students to reach calculus by 10th or 11th grade.

Still, Rifkin and Khavinson argue their strategy is not as simple as merely giving students next years work. The main difference between Russian Math and the math being taught in schools, they say, boils down to a methodology that emphasizes derivation over memorizationof learning the reasons behind the answersand a visual approach that helps students see the math, and therefore understand it better. Russian Math students also put in more face time with teachers: Since most kids sign up for 90 minutes to four hours a week in concentrated blocks, they theoretically get a chance to understand concepts more deeply. Classes are smaller, too, averaging around 12 students, and divided by ability levels, which means that teachers can teach to students very specific needs in a way that public school teachers just cant. Its almost like how you do athletics here, Rifkin says. Its not for your child to become an Olympic finalist. Math for us is not to become a mathematician, but to become a good thinker.

Wyle, whose kids had also tried the math-enrichment program Kumon but quickly lost interest, remembers being impressed the first time she took her then-first grader to sit in on an RSM class. They were doing algebra, she says. And the way they did it would be, like, two kids balanced on a seesaw. And underneath one kid, there might be the number seven, and underneath the other kid and a weight is a number five. And then they would ask the students, What does the weight weigh? and of course the kids would say two because they could see it, right? Their whole approach was built around seeing the math, and I myself could sort of see quantum mechanics by the time that class was over. They were teaching kids to see and understand. Not just do.

Most important, students seem to like it. Newton mom Ellen Chu and her husband initially enrolled their daughter in RSM because she told them she hated math. This year, she started her first year of college at Oxford, majoring in math and computer science. I think my daughter came to love math because RSM introduced her to more-complex, nuanced math, which she found exciting, Chu says. Based on her experience, I think the school is trying to help its students think, problem-solve, and enjoy math.

Meanwhile, Wyle says RSMs teachers are warm and invested and create a tightknit community. Even from the very early days, she recalls, when the kids got high SAT scores, when they were merit finalists or stuff like that, for the teachers, it was like our kids were their kids.

Make no mistake, Russian Math can be an adjustment, especially for students who start when theyre older. Four hours of extra math every week is a lot, and theres homework, too. Maria Rubio, whose two daughters attended RSMs Framingham and Wellesley locations and who first heard about the program from a Polish mom at her kids bus stop, says her older daughter was moved up a level at RSM after a teacher there said she wasnt being challenged enough. The first year, the poor girl, Rubio says. They would give her stacks of hundreds of exercises just so she could catch up. Rubio asked the teacher if she was really sure her daughter was ready. She told me, Im not going to keep her in the lower class because, I mean, this is about challenging them, Rubio recalls. This is not about anything else. She doesnt belong there. She has to go to the other level. So she struggled but she made it and she became really, really fluent and now I always thank those big stacks of exercises.

In another success story, Belmonts Alanna Fincke sent her son to Russian Math last year as an eighth grader at his request. For Jonah, the way they taught made more logical sense to him than the way it was taught in his public school, Fincke says. Hed previously attended, and liked, Kumon. And yet, Fincke says, There was something about Russian Math that just seemed like a challenge, and he really liked that.

All of the kids I talked to said Russian Math puts them at an advantage in their regular math classes, where they tend to do better on testsor, at least, they dont have to study as hard to do okay. Rifkin believes that better grades arent all theyre getting: Grades matter, but theyre also more confident, she says. I see this in the girls we teach, especially. They enjoy their smartness tremendously. Theyre not shy of being smart, or of having a voice in class. I see them when they start with us and I see them when they leave us and theyre different people.

Photo by Jason Grow

Not everyone is convinced, though, that there is anything particularly special going on at Russian Math, other than kids spending four hours a weekor moreworking on arithmetic. (In Jonahs case, his parents even hired a tutor to help him do better in Russian Math, which may be the next level of the mathematical arms race.) Parents may think it is helping their kids, but Harvards Jon Star says there is no evidence that enrollment in RSM translates into better grades in schools or better standardized test scores. Whats more, he takes issue with the idea that Russian math is somehow better than the math thats taught in public schools. In fact, he doesnt even think its demonstrably unique. Part of the RSM sales pitch, Star says, is that its coursework engages students more, and differently, than their normal school curriculum. But he says theres no universal school of math in Russia that everyones following and that is significantly different from what is taught in the U.S. Id urge parents to be cautious with that claim, he says, because just because the teacher teaches math while speaking with a Russian accent doesnt make it better.

What Star suspects is really going on is that Russian Math is merely teaching kids the same math they learn in their regular curriculum, just earlier and fasterwhich he says is pretty low-hanging fruit in the world of math education.

Meanwhile, Hilary Kreisberg, director of the Center for Math Achievement at Lesley University and a former fifth-grade teacher turned math coach, says her experiences with RSM students have led her to question the claim that Russian Math focuses more on developing a deep understanding of math instead of memorization. In fact, she has seen the opposite. From what Ive seen, they come in well above their grade-level standards in terms of memorization, but not in terms of content understanding, she says. Many of them very quickly get to an answer or can compute in a fast way, but they cant necessarily explain to me what theyre doing or why theyre doing it. And explanations, she says, are a critical component of mathematics. In public school teaching, we are very strictly taught that the goal is not to accelerate, Kreisberg says. The goal is not to extend their thinking into another grade level, but to go deeper with the current grade-level standards because theres always more you could learn about a topic.

Many parents, though, love the accelerated curriculum and feel it gives their kids an edge, not just in high school but in the ever more competitive quest for admission to an elite university. Every last one of the dozen-plus RSM parents I spoke with told me that their child was way ahead of their regular math class, which they viewed as evidence of a less-than-challenging curriculum and further proof of how far behind American math is.

Star and Kreisberg say this attitude is part of a misguided race to calculus, where the view is that the sooner a student gets there, the better. Its not about helping your kid get to where they should be in math to really understand the math deeply. Its about going fast so you can get ahead of everyone else, with the perception that that helps. And for what? Star asks. There is zero evidence that it helps your child to take calculus in 10th grade.

Parents of RSM students note with pride that their kids are two or three years ahead of their peers. / Photo by Jason Grow

Not surprisingly, the popularity of Russian Math has posed a significant challenge for schools, whose teachers now find themselves struggling with how to instruct an increasing number of students whove already seen the material. The range in students abilities in a single classroom has always been a hurdle for educators. Now that rangeand the challengeis far bigger.

Ultimately, it isnt just an issue for teachers, but for the very kids who attend RSM. Many of them are bored in math class and have lost their curiosity, Kreisberg says, which is an essential part of math. My experience with students who have engaged in Russian Math is that they oftentimes have this arrogant disposition of, I already know this, I dont need to learn it again, even though they might be missing foundational gaps because theyre so accelerated. She continues, They dont want to learn a different way to solve something. They just want to get to the answer because they can. I have a harder time teaching those students than any other students that I work with.

It isnt just RSM kids whose learning in school is affected, but non-RSM kids, too, who begin to question their abilities even if theyre performing perfectly well at grade level. Kreisberg says that when RSM kids in class make rapid-fire calculations, the other students begin to feel theyre not good at math, and that to be good they need to be in the RSM program.

In the worst cases, the Russian Math kids are rude and disrespectful to their teachers. Chu recalls hearing her daughter describe a situation at her high school in which RSM students were constantly correcting and criticizing their regular school teacher. The word my daughter used, Chu says, was insufferable.

Kreisberg views the popularity of Russian Math as representative of a general lack of respect for teachers. Who determines if a child is too advanced for their regular school curriculum? she says. Its usually the parents, who are not qualified educators. But theyre not going into hospitals and telling doctors, Hey, you should use this more-advanced procedure because I read about it somewhere. Nobody questions what we do in medicine, but we question educators all the time because we dont value our teachers. While thats likely not entirely truemedical professionals have complained about this very problem since the first season of ERseveral parents did admit that they enrolled their children in RSM without ever bothering to talk to their kids school. We realized early on that the school didnt have accommodations for our daughters specific level, Rubio says. But we never asked the school about it. Because we had RSM.

At the same time, many RSM parents and students seem to expect teachers to teach to their accelerated level, and at least some schools seem to be complying. According to RSM, Newton South has added new courses and additional levels of math or provided RSM kids with extra homework in order to keep these kids engaged (and their parents happy).

In most cases, though, teachers dont teach to the RSM kids accelerated levels, presumably because theyre busy teaching the rest of the students who are learning on the normal public school schedule. Rubio says one of her daughters was separated out of class for a year. They would give her a packet with some supposedly more-advanced stuff, and she would go out into the hallway with another girl and do work together, she says. And I said, But what do you do if you have a question? And she would say, Oh, I just ask [the other girl]. And I said, What if she has a question? And she said, She asks me.

RSM also says that other towns, including Weston and Winchester, are taking more-extreme measures. They have started specifically asking parents to refrain from enrolling their children in the Russian School of Mathematics, something that only seems to spark more ire among parentsand which gets tricky when teachers from those districts are spotted dropping off their own kids there. (None of the schools mentioned in this article, nor many others contacted for this story, responded to repeated requests for comment.) Star thinks schools could do a better job communicating their plan for attending to advanced childrens math instruction needs, instead of just discouraging enrollment in RSM. But maybe in some communities, he says, it already feels like they lost the battle.

There is also the issue of elitism. RSM says that classes start at $20 an hour, which may be a handy way of making it sound affordable; tuition for most students is at least $2,000 per course. It is likely not a coincidence that its locations are all in upper-middle-class towns. According to a 2019 report about after-school math from Pioneer Education, all but one of the Massachusetts towns where RSM has locations have a median household income of $93,600 or more, compared to the statewide average of $67,800; five are among the 20 Massachusetts communities with the highest median income. While Kumon has partnered with schools in inner cities to provide its program to low-income families, RSM has no similar program. (It does, however, offer financial aid to 10 to 15 percent of its students.)

Chu says that in middle school, her daughters teachers were openly critical of RSMs elitist nature, and Chu doesnt disagree with them. Neither does Wyle, saying, I understand why [the schools] would have that defensive position, because its tough for them when they have some significant cohort in their class who are getting this world-class math education, and then theres everybody else. But from my perspective, I never would have been at the Russian School of Mathematics if it hadnt been for Westons bad math curriculum.

On a Saturday morning in late January, the lobby at RSMs Newton headquarters has become the new soccer-field sidelines: Moms in Canada Goose parkas chat animatedly, clutching Yeti mugs, as sleepy kids shuffle into their respective classrooms. The parking lot is a showroom of Range Rovers and white Audis. My God, we spent so much money on it, says mom Maria Rubio of the years her two daughters attended RSM. But it is amazing.

Continued here:
The New New Math: Inside the Russian School of Mathematics - Boston magazine

Read More...

Your Mind Is the Most Important Factor in Successful Investing – Nasdaq

Monday, April 6th, 2020

Investment icon Warren Buffett once said, "Success in investing doesn't correlate with IQ ... what you need is the temperament to control the urges that get other people into trouble in investing." In other words, it's not about being smart, it's about how you think. Warren Buffett actually learned that from value investing legend Benjamin Graham, who was extolling the importance of emotion in investing before Buffett bought his first stock. In fact, there's now a whole branch of finance that looks at this issue, called behavioral finance. It's basically a blend of psychology and finance that examines all of our all-too-frequent mental mistakes. You make them -- but we all do.

If you want to be a successful investor, you need to understand these misconceptions. Here's a primer on why your mind is the most important factor in investing.

If you ask a room full of people if they are above-average drivers, almost everyone will raise their hand. That's statistically impossible, since roughly half have to be worse than average. This is anecdotal, but it gets to the heart of the matter. We all think we are better than we really are. And in investing that's a big blind spot, and one that will often lead you astray.

Image source: Getty Images

This isn't to suggest that you (yes, you specifically) aren't smart and capable. It's just that you are likely to overestimate just how smart and capable you are. That will lead you to believe that what you are doing is right without question. In other words, although terribly cliche, the first thing you need to do is admit you have a problem. And once you do that, you can start to look at ways that you might be wrong about your investment decisions.

This, however, never ends, because you will be human all of your life. So you'll need to be on guard forever. Getting "you" right is a lifetime effort.

The human mind has two broad ways of thinking. One is slow and calculated, the other quick and emotional. By nature we tend to use the quick way most often. It makes sense -- if there's a car bearing down on us as we cross the street, we can't sit around and contemplate what to do. Investing, however, requires us to move past quick decisions and use the vast processing power of our minds. Sounds easy, but when we're under stress we usually revert to quick, emotional thinking. Investing is stressful even on a good day. (Today, with COVID-19 pushing us into a bear market and likely into a recession, it's even more stressful than usual.)

You need to make changes to your process so you limit the stress and give your calculating mind time to work. For example, you might stop placing trades during market hours, and instead set up your trades before or after the market closes using limit orders. That way you don't feel pressure to act. Or instead of watching the market every second looking for a stock to buy, look at companies and create a list of names you'd like to own. After you have that list, figure out the prices you'd be willing to pay, and only buy them at those prices. You get the idea -- pull yourself out of high-stress situations and you'll give yourself the space to make better choices.

You make mistakes, we all do. It's actually a good thing, because it's the way human beings learn. That, however, doesn't mean you should accept mistakes, especially since we're prone to making the same ones over and over again.

If you like big dividend yields, for example, you'll probably find yourself attracted to companies where the dividends are at severe risk of being cut. Kinder Morgan (NYSE: KMI), for example, had a yield in the double digits before it cut its payout in 2016 because its aggressive use of leverage limited its access to capital in a difficult energy market. The midstream giant is still trying to rebuild trust with investors.

If you find value stocks attractive, you'll probably find yourself looking at stocks that are cheap for a reason. Sears Holdings had iconic retail names and owned a huge collection of physical properties, but none of that allowed it to avoid the fact that the retailer was increasingly falling behind peers. It ended up in bankruptcy court, effectively wiping out equity investors.

And if you think growth is the best way to go, you'll likely have to stop yourself from buying wildly overpriced shares driven by nothing more than a wish and prayer. There are any number of manias that can be used to illustrate this one, but one of the best is internet stocks in the late 1990s. Booking Holdings (NASDAQ: BKNG) is a good example. It went public under the Priceline name in 1999 at the peak of the hype, rocketed higher, and then lost 99% of its value over the next two years. It was a real business, and still is, but it took roughly a decade for the stock to get back to its IPO price after that decline. Obviously, there was too much hope and hype in the price when the stock came public.

If you know your investment style, then you need to figure out what can go wrong with that style. For example, Bruce Berkowitz, the manager of Fairholme Fund, has a list of things that companies often do that lead to disaster. He is, essentially, trying to kill a company before he buys it. The list includes things like taking on too much debt and spending more cash then a business can generate.

There are three big takeaways from this list. One, Berkowitz examined his process and figured out where he often goes wrong -- recognizing that he isn't infallible. Two, he created a list to test his decisions -- questioning himself before he acts. And three, the list forces him to slow down and work outside of the pressure cooker that is Wall Street -- removing the intensity of time constraints.

These are just three points to consider, but they cover a lot of ground. And they get to the heart of the matter. You are your own worst enemy when it comes to investing. In fact, you will dramatically improve your investment performance simply by limiting the mistakes you make. It isn't an easy journey, but it's one that good long-term investors have to go on at some point. If you don't, you'll continue to make the same mistakes over and over again, and your investment results will suffer for it.

But you have the power to do something about. First admit that, when it comes to investing, you have a problem -- and it's you.

10 stocks we like better than Kinder MorganWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Kinder Morgan wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of March 18, 2020

Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Booking Holdings and Kinder Morgan. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Excerpt from:
Your Mind Is the Most Important Factor in Successful Investing - Nasdaq

Read More...

Global Nerve Repair and Regeneration Industry – GlobeNewswire

Monday, April 6th, 2020

New York, April 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nerve Repair and Regeneration Industry" - https://www.reportlinker.com/p05799212/?utm_source=GNW 3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$11.8 Billion by the year 2025, Neurostimulation & Neuromodulation Devices will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 11% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$339.2 Million to the regions size and clout in the next 5 to 6 years. Over US$405.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Neurostimulation & Neuromodulation Devices will reach a market size of US$527.3 Million by the close of the analysis period. As the worlds second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.1% over the next couple of years and add approximately US$1.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others,

Read the full report: https://www.reportlinker.com/p05799212/?utm_source=GNW

NERVE REPAIR AND REGENERATION MCP13MARKET ANALYSIS, TRENDS, AND FORECASTS, FEBRUARY 2CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW Nerve Repair and Regeneration Market Set for a Rapid Growth Neurostimulation and Neuromodulation Devices: Largest Product Segment Biomaterials to Exhibit Rapid Growth Nerve Repair and Regeneration Market by Application US and Europe Dominate the Market, Asia-Pacific to Register the Fastest Growth

2. FOCUS ON SELECT PLAYERS Abbott Laboratories, Inc. (USA) AxoGen, Inc. (USA) Boston Scientific Corporation (USA) Integra LifeSciences Corporation (USA) LivaNova, PLC (UK) Medtronic plc (USA) NeuroPace, Inc. (USA) Nevro Corporation.(USA) Orthomed S.A.S. (France) Polyganics B.V. (The Netherlands) Stryker Corporation (U.S.) Synapse Biomedical Inc. (U.S.) Synovis Micro Companies Alliance, Inc. (USA)

3. MARKET TRENDS & DRIVERS High Incidence of Brain Disorders and Nerve Injuries: Primary Market Driver EXHIBIT 1: Annual Incidence of Adult-Onset Neurologic Disorders in the US EXHIBIT 2: Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy EXHIBIT 3: Global Alzheimer's Prevalence by Age Group EXHIBIT 4: Diagnosed Prevalence Cases of Parkinsons Disease Across Select Countries Classification of Nerve Injuries Recent Developments in Spinal Cord Injury Treatment Rising Geriatric Population and Subsequent Growth in Prevalence Of Neurological Disorders EXHIBIT 5: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2and 2050 Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration New Biomaterials Pave the Way for Innovative Neurodegeneration Therapies Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury Innovative Nerve Conduits from Stryker Technological Advancements and Product Innovations - A Key Growth Driver Neurostimulation Allows Paralyzed People to Regain Leg Movement Neurostimulator to Treat Neurological Conditions Micro-Implantable Solution for Neurostimulation Parasym Device for Neurostimulation Boston Scientifics Spinal Cord Stimulation Improves Quality of Life Intellis Platform Presents Smallest Implantable Neurostimulator Innovation in Deep Brain Stimulation for Parkinsons Disease Innovations in Spinal Cord Stimulation for Pain Smart Neuromodulation: The Combination of AI and Neuromodulation Technologies New Dynamic Lead Interface Design for Neurostimulator Devices Wireless SCS Neuromodulation Therapy: An Alternative to Traditional SCS System Select Recent Approvals of Neuro-stimulation and Neuromodulation Devices Select Launches in Spinal Cord Stimulation (SCS) Market Select Launches in Deep Brain Stimulation (DBS) Market Select Neurostimulation Devices in Clinical Trials Select Neuromodulation Devices in Clinical Trials

4. GLOBAL MARKET PERSPECTIVE Table 1: Nerve Repair and Regeneration Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 2: Nerve Repair and Regeneration Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 Table 3: Nerve Repair and Regeneration Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 Table 4: Neurostimulation & Neuromodulation Devices (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025 Table 5: Neurostimulation & Neuromodulation Devices (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 Table 6: Neurostimulation & Neuromodulation Devices (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 Table 7: Biomaterials (Product) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 Table 8: Biomaterials (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 Table 9: Biomaterials (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 Table 10: Neurostimulation & Neuromodulation Surgeries (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 11: Neurostimulation & Neuromodulation Surgeries (Application) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2009-2017 Table 12: Neurostimulation & Neuromodulation Surgeries (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 Table 13: Neurorrhaphy (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025 Table 14: Neurorrhaphy (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 Table 15: Neurorrhaphy (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 Table 16: Nerve Grafting (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 17: Nerve Grafting (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2009-2017 Table 18: Nerve Grafting (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 Table 19: Stem Cell Therapy (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2through 2025 Table 20: Stem Cell Therapy (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017 Table 21: Stem Cell Therapy (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 Table 22: Hospitals & Clinics (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025 Table 23: Hospitals & Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 Table 24: Hospitals & Clinics (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 Table 25: Ambulatory Surgery Centers (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025 Table 26: Ambulatory Surgery Centers (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017 Table 27: Ambulatory Surgery Centers (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Table 28: United States Nerve Repair and Regeneration Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 Table 29: Nerve Repair and Regeneration Market in the United States by Product: A Historic Review in US$ Thousand for 2009-2017 Table 30: United States Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 31: United States Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 Table 32: Nerve Repair and Regeneration Historic Demand Patterns in the United States by Application in US$ Thousand for 2009-2017 Table 33: Nerve Repair and Regeneration Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 Table 34: United States Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 Table 35: Nerve Repair and Regeneration Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2009-2017 Table 36: Nerve Repair and Regeneration Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 CANADA Table 37: Canadian Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 Table 38: Canadian Nerve Repair and Regeneration Historic Market Review by Product in US$ Thousand: 2009-2017 Table 39: Nerve Repair and Regeneration Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 Table 40: Canadian Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 Table 41: Nerve Repair and Regeneration Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 Table 42: Canadian Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 43: Canadian Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2to 2025 Table 44: Nerve Repair and Regeneration Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 Table 45: Canadian Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 JAPAN Table 46: Japanese Market for Nerve Repair and Regeneration: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 Table 47: Nerve Repair and Regeneration Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 Table 48: Japanese Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 49: Japanese Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 50: Japanese Nerve Repair and Regeneration Market in US$ Thousand by Application: 2009-2017 Table 51: Nerve Repair and Regeneration Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 Table 52: Japanese Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 53: Japanese Nerve Repair and Regeneration Market in US$ Thousand by End-Use: 2009-2017 Table 54: Nerve Repair and Regeneration Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 CHINA Table 55: Chinese Nerve Repair and Regeneration Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 Table 56: Nerve Repair and Regeneration Historic Market Analysis in China in US$ Thousand by Product: 2009-2017 Table 57: Chinese Nerve Repair and Regeneration Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 58: Chinese Demand for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 59: Nerve Repair and Regeneration Market Review in China in US$ Thousand by Application: 2009-2017 Table 60: Chinese Nerve Repair and Regeneration Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 61: Chinese Demand for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 62: Nerve Repair and Regeneration Market Review in China in US$ Thousand by End-Use: 2009-2017 Table 63: Chinese Nerve Repair and Regeneration Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 EUROPE Table 64: European Nerve Repair and Regeneration Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 Table 65: Nerve Repair and Regeneration Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 Table 66: European Nerve Repair and Regeneration Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 Table 67: European Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 Table 68: Nerve Repair and Regeneration Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017 Table 69: European Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 70: European Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 Table 71: Nerve Repair and Regeneration Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 Table 72: European Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 73: European Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 Table 74: Nerve Repair and Regeneration Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 Table 75: European Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 FRANCE Table 76: Nerve Repair and Regeneration Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 Table 77: French Nerve Repair and Regeneration Historic Market Scenario in US$ Thousand by Product: 2009-2017 Table 78: French Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 79: Nerve Repair and Regeneration Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025 Table 80: French Nerve Repair and Regeneration Historic Market Review in US$ Thousand by Application: 2009-2017 Table 81: French Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 82: Nerve Repair and Regeneration Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025 Table 83: French Nerve Repair and Regeneration Historic Market Review in US$ Thousand by End-Use: 2009-2017 Table 84: French Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 GERMANY Table 85: Nerve Repair and Regeneration Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 86: German Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 87: German Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 88: Nerve Repair and Regeneration Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 Table 89: German Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by Application: 2009-2017 Table 90: Nerve Repair and Regeneration Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 Table 91: Nerve Repair and Regeneration Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 Table 92: German Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by End-Use: 2009-2017 Table 93: Nerve Repair and Regeneration Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 ITALY Table 94: Italian Nerve Repair and Regeneration Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 Table 95: Nerve Repair and Regeneration Historic Market Analysis in Italy in US$ Thousand by Product: 2009-2017 Table 96: Italian Nerve Repair and Regeneration Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 97: Italian Demand for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 98: Nerve Repair and Regeneration Market Review in Italy in US$ Thousand by Application: 2009-2017 Table 99: Italian Nerve Repair and Regeneration Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 100: Italian Demand for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 101: Nerve Repair and Regeneration Market Review in Italy in US$ Thousand by End-Use: 2009-2017 Table 102: Italian Nerve Repair and Regeneration Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 UNITED KINGDOM Table 103: United Kingdom Market for Nerve Repair and Regeneration: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 Table 104: Nerve Repair and Regeneration Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 Table 105: United Kingdom Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 106: United Kingdom Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 107: United Kingdom Nerve Repair and Regeneration Market in US$ Thousand by Application: 2009-2017 Table 108: Nerve Repair and Regeneration Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 Table 109: United Kingdom Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2to 2025 Table 110: United Kingdom Nerve Repair and Regeneration Market in US$ Thousand by End-Use: 2009-2017 Table 111: Nerve Repair and Regeneration Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 SPAIN Table 112: Spanish Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 Table 113: Spanish Nerve Repair and Regeneration Historic Market Review by Product in US$ Thousand: 2009-2017 Table 114: Nerve Repair and Regeneration Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 Table 115: Spanish Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 Table 116: Nerve Repair and Regeneration Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 Table 117: Spanish Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 118: Spanish Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2to 2025 Table 119: Nerve Repair and Regeneration Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 Table 120: Spanish Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 RUSSIA Table 121: Russian Nerve Repair and Regeneration Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 Table 122: Nerve Repair and Regeneration Market in Russia by Product: A Historic Review in US$ Thousand for 2009-2017 Table 123: Russian Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 124: Russian Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 Table 125: Nerve Repair and Regeneration Historic Demand Patterns in Russia by Application in US$ Thousand for 2009-2017 Table 126: Nerve Repair and Regeneration Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025 Table 127: Russian Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 Table 128: Nerve Repair and Regeneration Historic Demand Patterns in Russia by End-Use in US$ Thousand for 2009-2017 Table 129: Nerve Repair and Regeneration Market Share Breakdown in Russia by End-Use: 2009 VS 2019 VS 2025 REST OF EUROPE Table 130: Rest of Europe Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 Table 131: Nerve Repair and Regeneration Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017 Table 132: Rest of Europe Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 133: Rest of Europe Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 Table 134: Nerve Repair and Regeneration Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 Table 135: Rest of Europe Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 136: Rest of Europe Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 Table 137: Nerve Repair and Regeneration Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 Table 138: Rest of Europe Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 ASIA-PACIFIC Table 139: Asia-Pacific Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 140: Nerve Repair and Regeneration Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017 Table 141: Asia-Pacific Nerve Repair and Regeneration Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 Table 142: Nerve Repair and Regeneration Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 Table 143: Asia-Pacific Nerve Repair and Regeneration Historic Market Scenario in US$ Thousand by Product: 2009-2017 Table 144: Asia-Pacific Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 145: Nerve Repair and Regeneration Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025 Table 146: Asia-Pacific Nerve Repair and Regeneration Historic Market Review in US$ Thousand by Application: 2009-2017 Table 147: Asia-Pacific Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 148: Nerve Repair and Regeneration Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025 Table 149: Asia-Pacific Nerve Repair and Regeneration Historic Market Review in US$ Thousand by End-Use: 2009-2017 Table 150: Asia-Pacific Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 AUSTRALIA Table 151: Nerve Repair and Regeneration Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 152: Australian Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 153: Australian Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 154: Nerve Repair and Regeneration Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 Table 155: Australian Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by Application: 2009-2017 Table 156: Nerve Repair and Regeneration Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025 Table 157: Nerve Repair and Regeneration Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 Table 158: Australian Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by End-Use: 2009-2017 Table 159: Nerve Repair and Regeneration Market Share Distribution in Australia by End-Use: 2009 VS 2019 VS 2025 INDIA Table 160: Indian Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 Table 161: Indian Nerve Repair and Regeneration Historic Market Review by Product in US$ Thousand: 2009-2017 Table 162: Nerve Repair and Regeneration Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 Table 163: Indian Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 Table 164: Nerve Repair and Regeneration Market in India: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 Table 165: Indian Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 166: Indian Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2to 2025 Table 167: Nerve Repair and Regeneration Market in India: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 Table 168: Indian Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 SOUTH KOREA Table 169: Nerve Repair and Regeneration Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 170: South Korean Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 171: Nerve Repair and Regeneration Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025 Table 172: Nerve Repair and Regeneration Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2018-2025 Table 173: South Korean Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Application: 2009-2017 Table 174: Nerve Repair and Regeneration Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025 Table 175: Nerve Repair and Regeneration Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2018-2025 Table 176: South Korean Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by End-Use: 2009-2017 Table 177: Nerve Repair and Regeneration Market Share Distribution in South Korea by End-Use: 2009 VS 2019 VS 2025 REST OF ASIA-PACIFIC Table 178: Rest of Asia-Pacific Market for Nerve Repair and Regeneration: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 Table 179: Nerve Repair and Regeneration Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 Table 180: Rest of Asia-Pacific Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 181: Rest of Asia-Pacific Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 182: Rest of Asia-Pacific Nerve Repair and Regeneration Market in US$ Thousand by Application: 2009-2017 Table 183: Nerve Repair and Regeneration Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025 Table 184: Rest of Asia-Pacific Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 185: Rest of Asia-Pacific Nerve Repair and Regeneration Market in US$ Thousand by End-Use: 2009-2017 Table 186: Nerve Repair and Regeneration Market Share Shift in Rest of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025 LATIN AMERICA Table 187: Latin American Nerve Repair and Regeneration Market Trends by Region/Country in US$ Thousand: 2018-2025 Table 188: Nerve Repair and Regeneration Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017 Table 189: Latin American Nerve Repair and Regeneration Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 Table 190: Latin American Nerve Repair and Regeneration Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 Table 191: Nerve Repair and Regeneration Historic Market Analysis in Latin America in US$ Thousand by Product: 2009-2017 Table 192: Latin American Nerve Repair and Regeneration Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 193: Latin American Demand for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 194: Nerve Repair and Regeneration Market Review in Latin America in US$ Thousand by Application: 2009-2017 Table 195: Latin American Nerve Repair and Regeneration Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 196: Latin American Demand for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 197: Nerve Repair and Regeneration Market Review in Latin America in US$ Thousand by End-Use: 2009-2017 Table 198: Latin American Nerve Repair and Regeneration Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 ARGENTINA Table 199: Argentinean Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 Table 200: Nerve Repair and Regeneration Market in Argentina in US$ Thousand by Product: A Historic Review for the Period 2009-2017 Table 201: Argentinean Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 202: Argentinean Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 Table 203: Nerve Repair and Regeneration Market in Argentina: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 Table 204: Argentinean Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 205: Argentinean Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 Table 206: Nerve Repair and Regeneration Market in Argentina: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 Table 207: Argentinean Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 BRAZIL Table 208: Nerve Repair and Regeneration Market in Brazil by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 Table 209: Brazilian Nerve Repair and Regeneration Historic Market Scenario in US$ Thousand by Product: 2009-2017 Table 210: Brazilian Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 211: Nerve Repair and Regeneration Quantitative Demand Analysis in Brazil in US$ Thousand by Application: 2018-2025 Table 212: Brazilian Nerve Repair and Regeneration Historic Market Review in US$ Thousand by Application: 2009-2017 Table 213: Brazilian Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 214: Nerve Repair and Regeneration Quantitative Demand Analysis in Brazil in US$ Thousand by End-Use: 2018-2025 Table 215: Brazilian Nerve Repair and Regeneration Historic Market Review in US$ Thousand by End-Use: 2009-2017 Table 216: Brazilian Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 MEXICO Table 217: Nerve Repair and Regeneration Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 218: Mexican Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 219: Mexican Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 220: Nerve Repair and Regeneration Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 Table 221: Mexican Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by Application: 2009-2017 Table 222: Nerve Repair and Regeneration Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025 Table 223: Nerve Repair and Regeneration Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 Table 224: Mexican Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by End-Use: 2009-2017 Table 225: Nerve Repair and Regeneration Market Share Distribution in Mexico by End-Use: 2009 VS 2019 VS 2025 REST OF LATIN AMERICA Table 226: Rest of Latin America Nerve Repair and Regeneration Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 Table 227: Nerve Repair and Regeneration Market in Rest of Latin America by Product: A Historic Review in US$ Thousand for 2009-2017 Table 228: Rest of Latin America Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 229: Rest of Latin America Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 Table 230: Nerve Repair and Regeneration Historic Demand Patterns in Rest of Latin America by Application in US$ Thousand for 2009-2017 Table 231: Nerve Repair and Regeneration Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025 Table 232: Rest of Latin America Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 Table 233: Nerve Repair and Regeneration Historic Demand Patterns in Rest of Latin America by End-Use in US$ Thousand for 2009-2017 Table 234: Nerve Repair and Regeneration Market Share Breakdown in Rest of Latin America by End-Use: 2009 VS 2019 VS 2025 MIDDLE EAST Table 235: The Middle East Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 236: Nerve Repair and Regeneration Market in the Middle East by Region/Country in US$ Thousand: 2009-2017 Table 237: The Middle East Nerve Repair and Regeneration Market Share Breakdown by Region/Country: 2009, 2019, and 2025 Table 238: The Middle East Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 Table 239: The Middle East Nerve Repair and Regeneration Historic Market by Product in US$ Thousand: 2009-2017 Table 240: Nerve Repair and Regeneration Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 Table 241: The Middle East Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 Table 242: Nerve Repair and Regeneration Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 Table 243: The Middle East Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 244: The Middle East Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2to 2025 Table 245: Nerve Repair and Regeneration Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 Table 246: The Middle East Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 IRAN Table 247: Iranian Market for Nerve Repair and Regeneration: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 Table 248: Nerve Repair and Regeneration Market in Iran: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 Table 249: Iranian Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 250: Iranian Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 251: Iranian Nerve Repair and Regeneration Market in US$ Thousand by Application: 2009-2017 Table 252: Nerve Repair and Regeneration Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025 Table 253: Iranian Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 254: Iranian Nerve Repair and Regeneration Market in US$ Thousand by End-Use: 2009-2017 Table 255: Nerve Repair and Regeneration Market Share Shift in Iran by End-Use: 2009 VS 2019 VS 2025 ISRAEL Table 256: Israeli Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 Table 257: Nerve Repair and Regeneration Market in Israel in US$ Thousand by Product: A Historic Review for the Period 2009-2017 Table 258: Israeli Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 259: Israeli Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 Table 260: Nerve Repair and Regeneration Market in Israel: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 Table 261: Israeli Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 262: Israeli Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 Table 263: Nerve Repair and Regeneration Market in Israel: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 Table 264: Israeli Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 SAUDI ARABIA Table 265: Saudi Arabian Nerve Repair and Regeneration Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 Table 266: Nerve Repair and Regeneration Historic Market Analysis in Saudi Arabia in US$ Thousand by Product: 2009-2017 Table 267: Saudi Arabian Nerve Repair and Regeneration Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 268: Saudi Arabian Demand for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 269: Nerve Repair and Regeneration Market Review in Saudi Arabia in US$ Thousand by Application: 2009-2017 Table 270: Saudi Arabian Nerve Repair and Regeneration Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 271: Saudi Arabian Demand for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 272: Nerve Repair and Regeneration Market Review in Saudi Arabia in US$ Thousand by End-Use: 2009-2017 Table 273: Saudi Arabian Nerve Repair and Regeneration Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 UNITED ARAB EMIRATES Table 274: Nerve Repair and Regeneration Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 275: United Arab Emirates Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 276: Nerve Repair and Regeneration Market Share Distribution in United Arab Emirates by Product: 2009 VS 2VS 2025 Table 277: Nerve Repair and Regeneration Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2018-2025 Table 278: United Arab Emirates Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Application: 2009-2017 Table 279: Nerve Repair and Regeneration Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025 Table 280: Nerve Repair and Regeneration Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2018-2025 Table 281: United Arab Emirates Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by End-Use: 2009-2017 Table 282: Nerve Repair and Regeneration Market Share Distribution in United Arab Emirates by End-Use: 2009 VS 2VS 2025 REST OF MIDDLE EAST Table 283: Nerve Repair and Regeneration Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 284: Rest of Middle East Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 285: Rest of Middle East Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 286: Nerve Repair and Regeneration Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 Table 287: Rest of Middle East Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by Application: 2009-2017 Table 288: Nerve Repair and Regeneration Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025 Table 289: Nerve Repair and Regeneration Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 Table 290: Rest of Middle East Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by End-Use: 2009-2017 Table 291: Nerve Repair and Regeneration Market Share Distribution in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025 AFRICA Table 292: African Nerve Repair and Regeneration Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 Table 293: Nerve Repair and Regeneration Market in Africa by Product: A Historic Review in US$ Thousand for 2009-2017 Table 294: African Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 295: African Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 Table 296: Nerve Repair and Regeneration Historic Demand Patterns in Africa by Application in US$ Thousand for 2009-2017 Table 297: Nerve Repair and Regeneration Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025 Table 298: African Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 Table 299: Nerve Repair and Regeneration Historic Demand Patterns in Africa by End-Use in US$ Thousand for 2009-2017 Table 300: Nerve Repair and Regeneration Market Share Breakdown in Africa by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

Total Companies Profiled:

Read the full report: https://www.reportlinker.com/p05799212/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Excerpt from:
Global Nerve Repair and Regeneration Industry - GlobeNewswire

Read More...

Multiple Sclerosis and Russian Treatments

Monday, March 30th, 2020

Do you have any desire to travel to Russia?

You might if you have multiple sclerosis.

People with multiple sclerosis (MS) in the United States and Canada are traveling to Russia for an experimental treatment thats a potential cure for the disease.

However, there are still a number of risks involved.

Hematopoietic Stem Cell Transplantation (HSCT) is a therapy for MS that has, in many cases, been shown to halt progression of the disease with a single treatment.

However, in North America, the procedure is still considered experimental and isnt widely available. Its also costly.

For individuals facing a potential lifetime of MS, the allure of a cure abroad is tantalizing.

According to Bruce Bebo, executive vice president of research at the National Multiple Sclerosis Society, HSCT treatment is promising. But he cautions there still arent enough rigorous clinical studies on it to weigh the real risks and benefits.

MS is a demyelinating autoimmune disease in which the bodys immune system begins to attack the myelin, the protective insulation of the nervous system.

These attacks cause scarring (sclerosis) that leads to a host of neurological symptoms from tremors and loss of vision, to difficulty with speech.

Its typically diagnosed in individuals between the ages of 20 and 40.

HSCT is a complex procedure that requires a bone marrow transplant similar to that used by oncologists for certain blood cancers.

The treatment is an attempt to reboot the immune system and stop it from attacking the brain and spinal cord.

One way to think about it is that you are reeducating and creating a new immune system, Bebo told Healthline. It appears that in many cases when you do this, that new immune system learns that the central nervous system isnt dangerous anymore and it doesnt attack it anymore.

In the first step of HSCT treatment, chemotherapy is used to stimulate the production of bone marrow stem cells and promote their release into the bloodstream. This blood is then drawn and stored.

The patient is then given a strong dose of more chemotherapy, most often in a hospital setting, for up to 11 days.

During that time, immune cells are either dramatically weakened or killed entirely.

Finally, the patients stored stem cells are infused back into the body, learning to leave the nervous system intact.

The process can be strenuous.

Patients must take antibiotics to fight off infections while their immune systems are suppressed.

They must also stay in the hospital for weeks at a time while their immune system rebuilds.

A recent study said that the average hospital stay after the stem cell infusion lasted between 10 and 160 days.

That may be a small price to pay to stop a chronic illness, especially for individuals diagnosed young.

Theres also the matter of the real price as in dollars.

I think [the reason] people are leaving the country has to do with cost, said Bebo. Im aware of many people who although they have to fight tooth and nail to get it, can get their insurance company to cover most or all the costs of this procedure in the U.S. Its expensive.

The cost is in the six-figure range. Healthline previously reported that it could be done in the United States for about $125,000.

Its a lot cheaper to go to Mexico or Russia to get HSCT therapy, where they will perform the therapy for a fraction of the cost, said Bebo.

There are also caveats to the treatment, dependent on the MS diagnosis.

Broadly speaking, there are two major types of MS: relapsing and progressive.

Relapsing, the more common form, is identified by intermittent attacks or exacerbations in which symptoms will worsen for a period and then dissipate.

As the disease progresses, the exacerbations get worse and the overall disability of the person increases.

Bebo describes progressive MS as a slow, steady progression of disability. Its less common but significantly more difficult to treat.

What little evidence we have at this point suggests that people with progressive MS dont respond to HSCT, said Bebo.

Typical drug regimens for relapsing MS, called disease modifying therapies (DMTs), also tend to be less effective for progressive MS.

This gap, as Bebo puts it, in treatment between progressive and relapsing MS may be driving medical tourism abroad.

Against doctors recommendations, patients may still elect to travel abroad to seek out HSCT for progressive MS.

New drugs, such as Ocrevus (ocrelizumab), have been approved more recently by the FDA for the treatment of progressive MS.

HSCT treatment isnt without risks.

Its not a trivial procedure and has been known for its serious mortality risk.

A study from 2017 concluded that while the procedure showed significant benefit against MS progression, the overall transplant-related mortality rate was about 2 percent.

As the procedure has improved, so have mortality rates. An older 2002 study of 85 MS patients treated with HSCT documented seven deaths in the group a mortality rate of about 8 percent.

I think there are still many neurologists who remember the older studies, the high risk of mortality, said Bebo, and until there is a rigorous, well-controlled study that documents the effectiveness and mortality risk, then I think some neurologists are going to be hesitant to recommend the therapy.

But Bebo and his colleagues at the MS society are also enthusiastic about the growing interest and research being done on HSCT.

I do see the neurology community being more accepting of this approach than they have in the past.

However, he emphasizes that HSCT isnt an MS panacea.

Depending on the diagnosis, the procedure must find its way into established therapy methods.

While HSCT is available in the United States today, it could still be years before its easily accessible and affordable.

We really look forward to the day when we have results from a really well-controlled, rigorous clinical trial to really tell us once and for all whats the full benefit of this, what are the full risks, and who is the person most likely to benefit from it, said Bebo.

Until then, people living with MS may choose to seek out treatment abroad, where the chance at a permanent cure may already be available.

In the race against a chronic illness, the U.S. medical system may just be moving too slowly for the young and the desperate.

View post:
Multiple Sclerosis and Russian Treatments

Read More...

Page 11«..10111213..20..»


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick